"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL3955216";"";"None";"918.34";"2";"8.63";"BDBM232401";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4C(=O)Cc3ccc(Cl)c(Cl)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"2450.0";"nM";"5.61";"";"405294";"UO_0000065";"6.11";"0.12";"-3.02";"3.95";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2031024";"";"None";"770.35";"2";"6.71";"BDBM50384355";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"6.27";"nM";"8.20";"";"405302";"UO_0000065";"10.65";"0.21";"1.49";"5.78";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2031031";"";"None";"742.30";"2";"7.14";"BDBM50384361";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2COc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"60.0";"nM";"7.22";"";"405305";"UO_0000065";"9.73";"0.19";"0.08";"5.52";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912240";"";"None";"847.65";"2";"10.03";"BDBM232454";"CCCCN(Cc1ccc(Cl)c(Cl)c1)c1ncc(Cl)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"160.0";"nM";"6.80";"";"405359";"UO_0000065";"8.02";"0.17";"-3.23";"6.04";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL375628";"";"None";"766.39";"2";"7.12";"8g";"COC1(Cc2cccc(Cl)c2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"8.83";"0.18";"-0.35";"5.05";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1824814";"";"None";"512.41";"2";"6.36";"17";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1cccc(-c2ccc(Cl)cc2Cl)c1";"IC50";"'='";"9980.0";"nM";"5.00";"";"";"UO_0000065";"9.76";"0.20";"-1.36";"6.90";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824817";"";"None";"498.39";"1";"6.57";"20";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1cccc(-c2cc(Cl)cc(Cl)c2)c1";"IC50";"'='";"2530.0";"nM";"5.60";"";"";"UO_0000065";"11.23";"0.23";"-0.97";"7.72";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824825";"";"None";"512.41";"2";"6.36";"28";"O=C(NS(=O)(=O)c1ccc(OCc2ccccc2)cc1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"2960.0";"nM";"5.53";"";"";"UO_0000065";"10.79";"0.22";"-0.83";"7.63";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824830";"";"None";"634.38";"2";"8.61";"33";"O=C(NS(=O)(=O)c1ccc(Oc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"2940.0";"nM";"5.53";"";"";"UO_0000065";"8.72";"0.18";"-3.08";"7.63";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2398292";"";"None";"377.43";"1";"5.09";"12a";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(=O)O)c2)o1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"14.99";"0.29";"0.57";"6.45";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398172";"";"None";"400.46";"0";"4.82";"59a";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CC3)n1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"17.20";"0.32";"2.07";"7.87";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1097075";"";"None";"524.60";"1";"3.79";"1";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4cccc(OCC(=O)O)c4)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"10.42";"0.20";"1.68";"6.07";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1164460";"";"None";"302.46";"0";"4.73";"1";"C[C@]12CCC[C@@](C)(C(=O)O)[C@@H]1CC[C@]13C[C@@H]4[C@H](C[C@H]12)[C@]4(C)C3";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1168411";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by fluorimetric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165962";"1";"Scientific Literature";"J Nat Prod";"2010";"None";"";"";""
"CHEMBL3947658";"";"None";"1025.53";"None";"None";"BDBM156386";"CN(CCOP(=O)(O)O)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"298864";"UO_0000065";"8.78";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3126113";"";"None";"466.49";"1";"5.56";"4";"O=C(O)c1ccc(-c2cccc3c(CCCOc4cccc5ccccc45)c(C(=O)O)nn23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1435948";"";"None";"418.47";"0";"1.37";"SID57260657";"COc1ccc(S(=O)(=O)N2CCN(C(=O)C3COc4ccccc4O3)CC2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1316816";"";"None";"383.23";"0";"3.57";"SID57264542";"Cc1ccccc1OCC(=O)OCC(=O)Nc1ncc(Cl)c(C)c1Cl";"IC50";"'='";"30364.0";"nM";"4.52";"";"Not Active";"UO_0000065";"11.79";"0.25";"0.95";"5.83";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1706577";"";"None";"359.36";"0";"4.40";"SID17409043";"O=C(N/N=C/c1cccc(F)c1)c1cc(-c2ccco2)nc2ccccc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3197662";"";"None";"313.27";"0";"1.91";"SID24828492";"Cc1nc2ccccn2c1C(=O)N/N=C/c1ccc([N+](=O)[O-])o1";"IC50";"'='";"55186.0";"nM";"4.26";"";"Not Active";"UO_0000065";"13.59";"0.25";"2.35";"3.70";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1307648";"";"None";"343.34";"0";"3.92";"SID17514202";"O=C(Oc1ccc2c(c1)O/C(=C\c1ccncc1)C2=O)c1ccccc1";"IC50";"'='";"15508.0";"nM";"4.81";"";"Not Active";"UO_0000065";"14.01";"0.25";"0.89";"7.34";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1272224";"";"None";"518.56";"1";"5.00";"BDBM142750";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CC(C)C)C2=O)C(=O)c2cc(O)c(O)c(CC(C)C)c2C1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"278890";"UO_0000065";"12.07";"0.22";"1.26";"4.20";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3943506";"";"None";"1123.67";"None";"None";"BDBM156405";"CC(C)(C)OP(=O)(O)OCO[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"298882";"UO_0000065";"7.74";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3287302";"";"None";"584.72";"2";"6.67";"23";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCCOc3ccccc3)s1)CC2";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.95";"0.27";"1.48";"7.79";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL426558";"";"None";"810.84";"2";"7.23";"8l";"COC1(Cc2ccccc2Br)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL373544";"";"None";"724.91";"2";"6.79";"10h";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4C#N)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"8.67";"0.17";"-0.51";"4.23";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL374097";"";"None";"785.05";"2";"7.61";"23h";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4C4CCCCC4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"9.19";"0.18";"-0.40";"5.63";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1095307";"";"None";"575.60";"2";"5.19";"12e";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3cccc([N+](=O)[O-])c3)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"9.94";"0.19";"0.53";"4.47";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2159743";"";"None";"2748.09";"None";"None";"BAD";"CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"3.02";"None";"None";"None";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1269075";"";"None";"614.65";"2";"6.17";"BDBM142753";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(CCc3ccccc3)c2C1=O";"IC50";"'='";"1790.0";"nM";"5.75";"";"278895";"UO_0000065";"9.35";"0.17";"-0.42";"3.85";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1592276";"";"None";"395.41";"0";"4.01";"SID56317368";"CCN(CC(=O)Nc1c(F)cccc1F)C(=O)/C=C/c1ccc2ccccc2n1";"IC50";"'='";"25257.0";"nM";"4.60";"";"Not Active";"UO_0000065";"11.63";"0.22";"0.59";"7.38";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1966952";"";"None";"396.83";"1";"5.31";"SID24814861";"Cc1ccc(/N=C/c2cc(Cc3ccccc3Cl)cc([N+](=O)[O-])c2O)c(O)c1";"IC50";"'='";"7216.0";"nM";"5.14";"";"Active";"UO_0000065";"12.96";"0.25";"-0.17";"5.36";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1558195";"";"None";"455.54";"0";"3.15";"SID57260290";"CCOc1ccc(NC(=O)c2cccc(-n3cccc3)c2)cc1S(=O)(=O)N1CCOCC1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1413866";"";"None";"365.42";"0";"2.16";"SID49680993";"N#Cc1c(SCC(=O)Nc2nncs2)sc2c(O)cc(O)nc12";"IC50";"'='";"96489.0";"nM";"4.02";"";"Not Active";"UO_0000065";"10.99";"0.24";"1.86";"3.04";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1330042";"";"None";"332.15";"0";"4.26";"SID22412771";"Cc1ccc(-c2cc(C(=O)O)c3cc(Br)ccc3n2)o1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL234338";"";"None";"302.24";"0";"1.99";"SID26666227";"O=c1cc(-c2ccc(O)cc2)oc2c(O)c(O)c(O)c(O)c12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1515153";"";"None";"426.84";"0";"4.92";"SID56422550";"O=C(C1=C(O)C(=O)N(c2nc3ccc(Cl)cc3s2)C1c1ccco1)c1ccco1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1453402";"";"None";"409.53";"0";"1.90";"SID56318505";"CC1(NC(=O)CCc2nc(O)c3c4c(sc3n2)CCCC4)CCS(=O)(=O)C1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1344422";"";"None";"276.30";"0";"3.89";"SID26731542";"Cc1ccc(-c2cc(-c3ccco3)c(C#N)c(O)n2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL578585";"";"None";"222.27";"0";"2.23";"SID4258396";"Cc1cc(NC(=O)Cc2cccs2)no1";"IC50";"'='";"53204.0";"nM";"4.27";"";"Not Active";"UO_0000065";"19.23";"0.39";"2.04";"7.75";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3192011";"";"None";"345.38";"0";"2.42";"SID24813146";"COc1cccc(/C=N/NC(=S)Nc2cccc(C(=O)O)c2)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1465511";"";"None";"317.19";"0";"1.42";"SID47202691";"O=C1NC(=S)NC(=O)C1=Cc1ccc(Br)s1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1417701";"";"None";"359.40";"0";"3.86";"SID49730403";"Cc1ccc(C)c(S(=O)(=O)Nc2ccc3oc(C)c(C(=O)O)c3c2)c1";"IC50";"'='";"93316.0";"nM";"4.03";"";"Not Active";"UO_0000065";"11.21";"0.22";"0.17";"4.17";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1348946";"";"None";"493.39";"0";"4.68";"SID49681028";"N#Cc1c(SCC(=O)Nc2nc3ccc(Br)cc3s2)sc2c(O)cc(O)nc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2325764";"";"None";"1013.71";"None";"None";"32, BM-1074";"Cc1c(C(=O)NS(C)(=O)=O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"IC50";"'='";"6.9";"nM";"8.16";"";"";"UO_0000065";"8.05";"None";"None";"None";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325762";"";"None";"950.63";"3";"10.84";"30";"CCCCn1c(C)c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c1-c1ccc(Cl)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"8.20";"0.16";"-3.04";"5.09";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL374303";"";"None";"734.34";"2";"7.58";"10c";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4Cl)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"8.38";"0.17";"-1.43";"4.93";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL266944";"";"None";"857.09";"3";"6.63";"23s";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(S(C)(=O)=O)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3311494";"";"None";"944.52";"3";"6.83";"20";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3ccccc3-c3ncc(Cl)cn3)CC2)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"8.13";"0.17";"0.85";"4.98";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"BDBM23223";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"IC50";"'='";"2720.0";"nM";"5.57";"";"320206";"UO_0000065";"10.73";"0.20";"-0.81";"3.58";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704832";"";"None";"678.68";"3";"8.42";"BDBM174848";"Cc1cc2c(C(=O)CCc3ccc(F)cc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)CCc3ccc(F)cc3)c(O)c(O)cc2c1O";"IC50";"'='";"140.0";"nM";"6.85";"";"320218";"UO_0000065";"10.10";"0.19";"-1.57";"4.41";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL221294";"";"None";"808.04";"2";"8.13";"8m";"COC1(Cc2ccccc2-c2ccccc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL375842";"";"None";"749.93";"2";"6.61";"8i";"COC1(Cc2ccccc2F)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"9.47";"0.19";"0.49";"5.30";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL384217";"";"None";"809.03";"3";"7.24";"23l";"COc1cccc(-c2ccccc2CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN(C)C)CSc5ccccc5)c([N+](=O)[O-])c4)cc3)CC2)c1";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"8.34";"0.16";"-0.49";"4.91";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3931799";"";"None";"966.57";"3";"9.24";"BDBM156394";"N#C[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"298873";"UO_0000065";"9.00";"0.18";"-0.54";"5.84";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3950997";"";"None";"958.59";"3";"8.61";"BDBM156389";"CCN(CCO)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](N)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"3.0";"nM";"8.52";"";"298867";"UO_0000065";"8.89";"0.18";"-0.09";"5.26";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3126115";"";"None";"767.34";"2";"7.36";"6";"CC(C)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCC(C)(C)C4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"6.64";"0.14";"-2.26";"4.40";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL221854";"";"None";"770.90";"2";"6.58";"23j";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"9.17";"0.18";"0.49";"5.52";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL387141";"";"None";"596.78";"2";"6.32";"1b";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NC(C)(C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"10.80";"0.21";"0.12";"5.30";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL374270";"";"None";"711.95";"2";"6.80";"8c";"CCCCCC1(OC)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"312.0";"nM";"6.51";"";"";"UO_0000065";"9.14";"0.18";"-0.29";"4.85";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL221218";"";"None";"711.95";"2";"6.66";"8b";"COC1(CC(C)(C)C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"8.93";"0.18";"-0.30";"4.74";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL192571";"";"None";"639.84";"2";"5.86";"1a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"10.07";"0.20";"0.58";"5.16";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4287383";"";"None";"976.12";"3";"5.93";"34a";"C[C@@H]1CC[C@H]2[C@@H](C)C(OCCN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)C[C@H]3CO)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4278774";"";"None";"974.10";"3";"6.48";"27i";"CO[C@H]1OC2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@]1(C)CC(=O)N1CCN(c5ccc(C(=O)NS(=O)(=O)c6ccc(NCC7CCOCC7)c([N+](=O)[O-])c6)c(Oc6cnc7[nH]ccc7c6)c5)CC1)[C@@]24OO3";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1094130";"";"None";"484.53";"0";"3.38";"1d";"O=C(O)COc1cccc(/C=c2\sc3n(c2=O)C(c2ccco2)C2=C(N=3)c3ccccc3CC2)c1";"IC50";"'='";"40400.0";"nM";"4.39";"";"";"UO_0000065";"9.07";"0.17";"1.01";"4.67";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1098755";"";"None";"548.60";"2";"5.42";"12b";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3ccccc3F)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"9.49";"0.18";"-0.21";"6.14";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1165508";"";"None";"318.46";"0";"3.70";"3";"C[C@]12CCC[C@@](C)(C(=O)O)[C@@H]1CC[C@]13C[C@@H]4[C@H](C[C@H]12)[C@]4(CO)C3";"IC50";"'='";"220000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1168411";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by fluorimetric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165962";"1";"Scientific Literature";"J Nat Prod";"2010";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"2, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"8.84";"0.18";"-0.69";"5.61";"0";"CHEMBL1072271";"Inhibition of Bcl-xL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157656";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL266944";"";"None";"857.09";"3";"6.63";"23s";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(S(C)(=O)=O)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"9.1";"nM";"8.04";"";"";"UO_0000065";"9.38";"0.19";"1.41";"4.96";"0";"CHEMBL909601";"Displacement of Bad-derived peptide from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"Gossypol";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"12.15";"0.23";"-0.08";"4.05";"0";"CHEMBL647263";"Inhibitory concentration against Bcl-xl";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144902";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL1476707";"";"None";"390.42";"0";"1.85";"SID57263880";"COc1cccc(C(=O)OCC(=O)Nc2sc3c(c2C(N)=O)CCC3)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1164030";"";"None";"348.48";"0";"3.64";"7";"CO[C@@]1(C)C[C@]23CC[C@@H]4[C@](C)([C@H](O)CC[C@@]4(C)C(=O)O)[C@H]2C=C[C@@H]1C3";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1168411";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by fluorimetric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165962";"1";"Scientific Literature";"J Nat Prod";"2010";"None";"";"";""
"CHEMBL1163268";"";"None";"334.46";"0";"2.98";"6";"C[C@]12[C@H](O)CC[C@@](C)(C(=O)O)[C@@H]1CC[C@]13C[C@@H](C=C[C@@H]12)[C@@](C)(O)C3";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1168411";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by fluorimetric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165962";"1";"Scientific Literature";"J Nat Prod";"2010";"None";"";"";""
"CHEMBL1507764";"";"None";"280.76";"1";"5.03";"SID49644390";"Clc1cccc(C2Nc3cccc4cccc(c34)N2)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1609276";"";"None";"406.19";"0";"2.81";"SID56317951";"O=C1COc2ccc(C(=O)COC(=O)/C=C/c3ccc(Br)o3)cc2N1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL134871";"";"None";"276.29";"0";"2.23";"6A1";"COc1cc2cccc(OC)c(=O)c2c(OC)c1OC";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647263";"Inhibitory concentration against Bcl-xl";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144902";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL1359564";"";"None";"448.55";"0";"4.34";"SID857194";"CC1(C)Cc2c(C#N)c(N3CCN(C(=O)c4ccco4)CC3)nc(-c3ccco3)c2CS1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1359782";"";"None";"407.34";"0";"3.11";"SID22401755";"O=C1NC(=O)N(Cc2ccco2)C(=O)/C1=C/c1ccc(-c2cccc([N+](=O)[O-])c2)o1";"IC50";"'='";"17627.0";"nM";"4.75";"";"Not Active";"UO_0000065";"11.67";"0.22";"1.64";"3.50";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1360150";"";"None";"406.19";"0";"2.82";"SID56315287";"O=C(COC(=O)/C=C/c1ccc(Br)o1)Nc1ccc2[nH]c(O)nc2c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3191557";"";"None";"331.24";"0";"1.37";"SID17409006";"O=C(N/N=C/c1ccncc1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342429";"";"None";"381.46";"0";"3.90";"SID14743266";"CCOc1ccc(N2CSC3=C(C#N)C(c4ccco4)CC(=O)N3C2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1454531";"";"None";"347.42";"0";"3.46";"SID56318899";"Cc1cccc(NC(=O)CNC(=O)c2cccc(-n3cccc3)c2)c1C";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL541496";"";"None";"728.84";"3";"7.58";"8q";"CCc1ccc(CCNC(=O)c2c(O)c(O)cc3c(O)c(-c4c(C)cc5c(C(=O)NCCc6ccc(CC)cc6)c(O)c(O)cc5c4O)c(C)cc23)cc1";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"8.28";"0.15";"-1.55";"3.36";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL374271";"";"None";"737.99";"2";"7.19";"8d";"COC1(CC2CCCCC2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"8.84";"0.17";"-0.67";"4.86";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1098322";"";"None";"570.67";"2";"5.69";"11";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4ccc(-c5cccc(C(=O)O)c5)cc4)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"26700.0";"nM";"4.57";"";"";"UO_0000065";"8.01";"0.15";"-1.12";"5.65";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1098324";"";"None";"630.72";"2";"5.61";"13";"COc1ccc(C2C3=C(N=c4s/c(=C\c5ccc(OCc6cccc(C(=O)O)c6)c(OC)c5)c(=O)n42)c2ccccc2CC3)cc1";"IC50";"'='";"17400.0";"nM";"4.76";"";"";"UO_0000065";"7.55";"0.14";"-0.85";"4.79";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1337575";"";"None";"286.29";"0";"2.20";"SID4245926";"COC(=O)c1ccccc1NC(=O)c1noc2c1CCC2";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1365170";"";"None";"252.72";"0";"3.91";"SID3711335";"O=C(CSc1ccc(Cl)cc1)c1ccco1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1301692";"";"None";"355.83";"0";"4.41";"SID3713414";"O=C(c1cc(-c2ccco2)nn1-c1cccc(Cl)c1)N1CCCCC1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3904423";"";"None";"862.29";"2";"8.18";"BDBM232388";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(N(C)C)ccc(Br)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"70.0";"nM";"7.16";"";"405279";"UO_0000065";"8.30";"0.17";"-1.03";"5.73";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2031021";"";"None";"759.37";"2";"6.58";"BDBM50384352";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4CC)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"405291";"UO_0000065";"10.54";"0.21";"1.42";"6.40";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917408";"";"None";"856.49";"2";"6.87";"BDBM232405";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(ccn4CCCN4CCOCC4)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"30.0";"nM";"7.52";"";"405298";"UO_0000065";"8.78";"0.17";"0.65";"5.41";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964058";"";"None";"882.53";"2";"6.33";"BDBM232413";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN2CCN(CCO)CC2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405310";"UO_0000065";"8.72";"0.17";"1.37";"5.19";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1689147";"";"None";"575.65";"2";"6.35";"4";"O=[N+]([O-])c1cc(S(=O)(=O)Nc2ncnc3cc(-c4ccc(F)cc4)ccc23)ccc1NCCSc1ccccc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"9.59";"0.19";"-0.83";"4.34";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1689145";"";"None";"956.62";"3";"9.69";"33";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3cc(N4CCN(CC5=C(c6ccc(Cl)cc6)CCC(C)(C)C5)CC4)ccc23)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"8.91";"0.18";"-1.17";"6.67";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL374309";"";"None";"779.00";"2";"7.23";"23i";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL385119";"";"None";"732.93";"3";"5.57";"23c";"COc1ccccc1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"9.68";"0.19";"1.53";"5.17";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"10.11";"0.20";"0.34";"6.42";"1";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL1453409";"";"None";"349.30";"0";"-0.46";"SID57269193";"Cc1ccc(OCC(=O)c2c(N)n(C)c(=O)n(C)c2=O)c([N+](=O)[O-])n1";"IC50";"'='";"21291.0";"nM";"4.67";"";"Not Active";"UO_0000065";"13.37";"0.26";"5.13";"3.07";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2030845";"";"None";"740.88";"2";"7.53";"3b";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1ccccc1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"9.96";"0.19";"-0.15";"5.78";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030847";"";"None";"698.85";"2";"6.84";"3d";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccccc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"11.39";"0.21";"1.12";"6.54";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030858";"";"None";"728.87";"2";"6.34";"3o";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1cccc(CO)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"10.73";"0.20";"1.48";"5.52";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3199337";"";"None";"345.45";"0";"4.06";"SID3712171";"CC(=N)/C(C#N)=C(/O)CSc1nnc(Nc2cccc(C)c2)s1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1981243";"";"None";"355.35";"0";"1.38";"SID863170";"O=c1nc2s/c(=C\c3ccco3)c(=O)n2nc1Cc1ccc(F)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1579209";"";"None";"455.54";"0";"3.30";"SID26670778";"Cc1cc[n+](-c2[n-]c(=O)sc2C=NNC(=O)CCn2c3ccccc3c3ccccc32)cc1";"IC50";"'='";"27638.0";"nM";"4.56";"";"Not Active";"UO_0000065";"10.01";"0.19";"1.26";"5.60";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1519408";"";"None";"339.78";"0";"3.68";"SID22400943";"Cc1ccc(/C=C(\C#N)C(=O)Nc2cccc3ncccc23)o1.Cl";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3358688";"";"None";"402.94";"1";"6.21";"I1";"O=C(CC(Sc1ccc(Cl)cc1)C(=O)O)c1ccc(C2CCCCC2)cc1";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"11.72";"0.24";"-1.49";"8.68";"0";"CHEMBL3383563";"Displacement of F-bid from human recombinant N-terminal His-tagged Bcl-xL (1 to 209) expressed in Escherichia coli BL21(DE3) after 120 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2398170";"";"None";"394.48";"0";"4.95";"48";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(=O)O)n2)s1";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"15.53";"0.31";"1.17";"7.00";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398278";"";"None";"375.38";"0";"4.93";"23";"C/C(=N\Nc1nc2ccccc2o1)c1ccc(-c2cccc(C(=O)O)c2C)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL165064";"ISOKAEMPFERIDE";"None";"300.27";"0";"2.59";"SID26657837";"COc1c(-c2ccc(O)cc2)oc2cc(O)cc(O)c2c1=O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1432884";"";"None";"295.34";"0";"2.99";"SID22412948";"CNc1ccccc(C(=O)/C=C/c2ccccc2OC)c1=O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468800";"";"None";"435.87";"0";"4.65";"SID22416620";"O=C(O)COc1ccccc1C(Nc1ccccn1)c1cc(Cl)c2cccnc2c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3309262";"";"None";"1043.65";"None";"None";"26";"CN(C)C(=O)COc1ccc(-c2ccc(Cl)cc2)c(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)c1";"IC50";"'='";"2090.0";"nM";"5.68";"";"";"UO_0000065";"5.44";"None";"None";"None";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL221805";"";"None";"776.00";"2";"8.59";"10k";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4-c4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"9.12";"0.18";"-1.51";"5.67";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3126120";"";"None";"901.08";"3";"9.03";"11";"Cc1cc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)nn12";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"9.36";"0.18";"-0.60";"4.55";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1095770";"";"None";"520.61";"1";"4.43";"9";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4ccc(/C=C/C(=O)O)cc4)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"12700.0";"nM";"4.90";"";"";"UO_0000065";"9.40";"0.18";"0.47";"6.05";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094172";"";"None";"494.57";"0";"3.78";"1a";"O=C(O)COc1cccc(/C=c2\sc3n(c2=O)C(c2ccccc2)C2=C(N=3)c3ccccc3CC2)c1";"IC50";"'='";"10300.0";"nM";"4.99";"";"";"UO_0000065";"10.08";"0.19";"1.21";"6.17";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1095309";"";"None";"560.63";"2";"5.29";"12h";"COc1ccc(C2C3=C(N=c4s/c(=C\c5ccc(-c6cccc(C(=O)O)c6)o5)c(=O)n42)c2ccccc2CC3)cc1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"9.21";"0.17";"-0.13";"5.49";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094644";"";"None";"720.80";"2";"6.68";"1g";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4cccc(OCC(=O)O)c4)c(=O)n31)c1ccc(OC(=O)c3ccccc3-c3ccccc3)cc1CC2";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2063882";"";"None";"1135.85";"None";"None";"6, BM-977";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"7.23";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063889";"";"None";"785.44";"2";"8.56";"13";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"88.3";"nM";"7.05";"";"";"UO_0000065";"8.98";"0.18";"-1.51";"6.35";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL217354";"";"None";"573.71";"2";"6.90";"5, TW-37";"CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O";"IC50";"'='";"6580.0";"nM";"5.18";"";"";"UO_0000065";"9.03";"0.17";"-1.72";"4.18";"0";"CHEMBL909446";"Displacement of FAM-Bak from human Bcl-xL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137390";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1385808";"";"None";"493.94";"0";"0.03";"SID855650";"CN(C)c1ccc(O)c2c1CC1CC3[C@@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@]3(O)C(=O)C1=C2O.Cl";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1346029";"";"None";"295.37";"0";"3.27";"SID49641503";"Cc1ccc(-c2csc3ncn(CC#N)c(=O)c23)cc1C";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3287292";"";"None";"430.49";"0";"4.20";"13";"O=C(O)c1cccc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"15.26";"0.29";"2.37";"6.88";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3287293";"";"None";"436.52";"0";"4.27";"14";"O=C(O)c1csc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)n1";"IC50";"'='";"91.0";"nM";"7.04";"";"";"UO_0000065";"16.13";"0.32";"2.77";"7.38";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL508232";"";"None";"597.79";"2";"5.10";"5";"CC1=C2O[C@]34OC5(CCN(C)CC5)O[C@@H]3C2=C(C(=O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]4C)[C@H](C)[C@H](O)[C@H]1C";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"8.87";"0.17";"0.20";"5.61";"0";"CHEMBL1002036";"Inhibition of interaction between GST-tagged Bcl-xl and Bak by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143433";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2159734";"";"None";"1075.80";"None";"None";"9";"Cc1c(C(=O)NCCCN2CCN(C)CC2)c(-c2cccc(N3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"7.72";"None";"None";"None";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3311480";"";"None";"944.52";"3";"6.83";"5";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1cnc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)nc1";"IC50";"'='";"2090.0";"nM";"5.68";"";"";"UO_0000065";"6.01";"0.12";"-1.15";"3.68";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3309312";"";"None";"1029.67";"None";"None";"27";"CN(C)CCOc1cccc(-c2ccc(Cl)cc2)c1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"7.27";"None";"None";"None";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3309283";"";"None";"991.60";"3";"8.16";"15";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC(S(=O)(=O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"7.74";"0.16";"-0.48";"4.82";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2030859";"";"None";"728.87";"2";"6.21";"3p";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(CO)nn1-c1ccccc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"11.11";"0.21";"1.89";"5.71";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030863";"";"None";"769.36";"2";"8.27";"3t";"CCCCCS(=O)(=O)NC(=O)c1ccc(-c2c(CO)nn(-c3ccc(Oc4cccc(Cl)c4)cc3)c2CCCC)c(C(=O)N2CCc3ccccc3C2)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"9.00";"0.18";"-1.35";"5.29";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031013";"";"None";"832.44";"2";"7.14";"13";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(S(=O)(=O)CC)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"8.20";"0.16";"-0.32";"4.38";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031015";"";"None";"869.48";"2";"7.06";"15";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OCCN5CCOCC5)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"8.36";"0.16";"0.21";"5.07";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031018";"";"None";"866.22";"2";"7.95";"18";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(I)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"8.46";"0.19";"-0.62";"6.02";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1574133";"";"None";"316.74";"0";"3.83";"SID7973023";"Cc1onc(-c2ccccc2Cl)c1C(=O)NCc1ccco1";"IC50";"'='";"65648.0";"nM";"4.18";"";"Not Active";"UO_0000065";"13.21";"0.26";"0.35";"6.13";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3287285";"";"None";"425.47";"1";"5.46";"4";"O=C(O)c1cccc(-c2ccc3cccc(C(=O)Nc4nc5ccccc5s4)c3c2)n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.10";"0.26";"0.54";"6.51";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1299990";"";"None";"341.32";"0";"2.60";"SID49647564";"COC(=O)c1ccccc1NCc1cc(=O)oc2cc(O)c(O)cc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1981200";"";"None";"371.37";"0";"3.29";"SID22400475";"COc1cccc(/C=N/NC(=O)c2cc3cc([N+](=O)[O-])ccc3s2)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1595525";"";"None";"282.34";"0";"2.64";"SID17385863";"O=C(O)C(C(=O)/C=C/c1ccco1)=C1SCCS1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1499658";"";"None";"474.49";"0";"4.20";"SID22400975";"COc1cccc(-n2c(SCc3cc(=O)oc4cc(O)c(O)cc34)nc3ccccc3c2=O)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1968789";"";"None";"357.39";"0";"2.90";"SID26724200";"C=CC/N=c1\scc(-c2ccco2)n1/N=C/c1ccc(O)c(O)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3192179";"";"None";"449.49";"0";"0.91";"SID22410067";"O=C(CCc1ccc(S(=O)(=O)N2CCOCC2)cc1)N/N=C/c1ccc(O)c(O)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1981150";"";"None";"359.43";"0";"3.84";"SID17511207";"C=CCc1cccc(/C=N/NC(=O)CNc2cccc3ccccc23)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1410381";"";"None";"273.29";"0";"2.44";"SID17504509";"O=[N+]([O-])c1cc(CN2CCCC2)c2cccnc2c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3195986";"";"None";"297.41";"0";"2.83";"SID3717601";"CC(=N)/C(C#N)=C(/O)CSc1nnc(NC(C)C)s1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1532198";"";"None";"464.91";"0";"4.11";"SID49729231";"O=C(O)CN1C(=O)/C(=C\c2cc([N+](=O)[O-])ccc2OCc2ccccc2Cl)SC1=S";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1377223";"";"None";"467.55";"0";"3.01";"SID22401224";"COc1ccc(NC(=O)c2c3c(nc4ccccc24)CCC3)cc1S(=O)(=O)N1CCOCC1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1417070";"";"None";"495.00";"1";"5.97";"SID24797173";"Cc1c(Cl)cccc1NS(=O)(=O)c1ccc2c(c1)C1C=CCC1C(c1ccc(C(=O)O)cc1)N2";"IC50";"'='";"50793.0";"nM";"4.29";"";"Not Active";"UO_0000065";"8.68";"0.17";"-1.68";"4.50";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1308606";"";"None";"371.82";"0";"4.50";"SID17506680";"O=C(/C=C/c1ccc(Cl)c([N+](=O)[O-])c1)Nc1ccc(N2CCCC2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3287282";"";"None";"414.49";"1";"5.21";"1";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N/Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"18.57";"0.35";"2.49";"8.80";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3126114";"";"None";"439.00";"1";"5.82";"5";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)O)cc3)CC2)C1";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"10.61";"0.21";"-1.16";"10.64";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1824813";"";"None";"512.41";"2";"6.36";"16a";"O=C(NS(=O)(=O)c1ccc(OCc2ccccc2)cc1)c1cccc(-c2cc(Cl)cc(Cl)c2)c1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"13.16";"0.27";"0.38";"9.31";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824819";"";"None";"498.39";"1";"6.57";"24";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1cccc(-c2cccc(Cl)c2Cl)c1";"IC50";"'='";"4080.0";"nM";"5.39";"";"";"UO_0000065";"10.81";"0.22";"-1.18";"7.44";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824820";"";"None";"498.39";"1";"6.57";"22";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1cccc(-c2ccc(Cl)cc2Cl)c1";"IC50";"'='";"1940.0";"nM";"5.71";"";"";"UO_0000065";"11.46";"0.24";"-0.86";"7.88";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL3986056";"";"None";"820.21";"2";"7.65";"BDBM232417";"Cc1c(Cl)c(C(=O)N(CCC(F)(F)F)CCC(F)(F)F)nn1-c1ccc(C(=O)NS(=O)(=O)c2ccc3ccccc3c2)cc1C(=O)N1CCc2ccccc2C1";"IC50";"'='";"30.0";"nM";"7.52";"";"405315";"UO_0000065";"9.17";"0.18";"-0.13";"6.18";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954559";"";"None";"818.35";"2";"7.52";"BDBM232418";"CCCCN(C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl)c1ccc2c(c1)OCCO2";"IC50";"'='";"30.0";"nM";"7.52";"";"405316";"UO_0000065";"9.19";"0.18";"0.00";"5.37";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917569";"";"None";"705.88";"2";"6.69";"BDBM232422";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)cc1C";"IC50";"'='";"30.0";"nM";"7.52";"";"405320";"UO_0000065";"10.66";"0.20";"0.83";"6.18";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894163";"";"None";"802.70";"2";"7.66";"BDBM232428";"CCCN(CCC)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C(F)(F)F)c1Cl";"IC50";"'='";"290.0";"nM";"6.54";"";"405326";"UO_0000065";"8.14";"0.17";"-1.12";"5.24";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2030850";"";"None";"832.98";"2";"9.32";"BDBM50384315";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"405339";"UO_0000065";"8.67";"0.16";"-2.10";"5.28";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2030851";"";"None";"790.94";"2";"8.64";"BDBM50384316";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"405342";"UO_0000065";"9.51";"0.18";"-1.12";"5.75";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890311";"";"None";"762.93";"2";"5.81";"BDBM232446";"CCCCN(CCCC)C(=O)c1cn(CC(=O)NC)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"70.0";"nM";"7.16";"";"405351";"UO_0000065";"9.38";"0.18";"1.34";"4.75";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL595134";"";"None";"331.40";"0";"3.01";"3";"N#CC1=C2C(=NC1=O)c1cccc3c(N4CCSCC4)ccc2c13";"IC50";"'='";"625.0";"nM";"6.20";"";"";"UO_0000065";"18.72";"0.35";"3.19";"10.99";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL1097075";"";"None";"524.60";"1";"3.79";"1";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4cccc(OCC(=O)O)c4)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"10.42";"0.20";"1.68";"6.07";"0";"CHEMBL1120824";"Displacement of FITC-labeled BH3 peptide from human Bcl-XL after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1095310";"";"None";"560.63";"2";"5.29";"12i";"COc1cccc(C2C3=C(N=c4s/c(=C\c5ccc(-c6cccc(C(=O)O)c6)o5)c(=O)n42)c2ccccc2CC3)c1";"IC50";"'='";"17400.0";"nM";"4.76";"";"";"UO_0000065";"8.49";"0.16";"-0.53";"5.06";"0";"CHEMBL1120824";"Displacement of FITC-labeled BH3 peptide from human Bcl-XL after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2312475";"";"None";"438.57";"1";"6.98";"8c";"CCCCCCNC1=C2C(=NC1=O)c1cccc3c(Oc4ccc(C(C)C)cc4)ccc2c13";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"15.48";"0.28";"-0.19";"13.40";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL1672071";"";"None";"364.40";"1";"5.38";"8a";"CC(C)c1ccc(Oc2ccc3c4c(cccc24)C2=NC(=O)C(C#N)=C23)cc1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"16.98";"0.30";"0.81";"9.91";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"1";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'='";"122.0";"nM";"6.91";"";"";"UO_0000065";"12.53";"0.25";"1.19";"5.84";"0";"CHEMBL858942";"Inhibitory activity against Bcl-XL in presence of alpha-1 acid glycoprotein from 1% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL221750";"";"None";"779.99";"3";"6.62";"23k";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4cccnc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"9.09";"0.18";"0.47";"5.03";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3287297";"";"None";"578.69";"2";"6.61";"18";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(CCCCOc3ccccc3)c(C(=O)O)n1)CC2";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"12.73";"0.24";"0.76";"7.04";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2398276";"";"None";"490.77";"1";"6.51";"22e";"C/C(=N\Nc1nc2cc(Br)ccc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"9.83";"0.23";"-1.69";"5.50";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398261";"";"None";"404.45";"0";"4.80";"71b";"O=C(O)c1coc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"17.86";"0.34";"2.42";"7.18";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"11.43";"0.23";"1.42";"7.26";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL554545";"";"None";"728.84";"3";"8.22";"8j";"Cc1cc(C)c(CNC(=O)c2c(O)c(O)cc3c(O)c(-c4c(C)cc5c(C(=O)NCc6c(C)cc(C)cc6C)c(O)c(O)cc5c4O)c(C)cc23)c(C)c1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"8.37";"0.15";"-2.12";"3.40";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2159737";"";"None";"908.55";"3";"9.58";"4, BM-903";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"9.05";"0.18";"-1.36";"5.36";"1";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL437148";"";"None";"781.00";"2";"4.96";"23e";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4S(C)(=O)=O)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"8.67";"0.17";"1.81";"4.17";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3287290";"";"None";"431.50";"1";"5.52";"9";"O=C(O)c1cccc(-c2ccc3scc(C(=O)Nc4nc5ccccc5s4)c3c2)n1";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"12.27";"0.24";"-0.23";"5.74";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL552735";"";"None";"586.68";"3";"8.08";"12e";"Cc1cc2c(CCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(CCc3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"10.89";"0.20";"-1.69";"5.26";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL551288";"APOGOSSYPOL";"None";"462.54";"2";"6.76";"2, Apogossypol";"Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.47";"0.23";"-0.99";"4.75";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL539481";"";"None";"741.62";"3";"8.80";"8k";"Cc1cc2c(C(=O)NC(C)c3ccc(Cl)cc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC(C)c3ccc(Cl)cc3)c(O)c(O)cc2c1O";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"8.86";"0.17";"-2.23";"3.66";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1824808";"";"None";"498.39";"1";"6.57";"13";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1ccc(-c2cc(Cl)cc(Cl)c2)cc1";"IC50";"'='";"49510.0";"nM";"4.30";"";"";"UO_0000065";"8.64";"0.18";"-2.26";"5.94";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824809";"";"None";"512.41";"2";"6.36";"13a";"O=C(NS(=O)(=O)c1ccc(OCc2ccccc2)cc1)c1ccc(-c2cc(Cl)cc(Cl)c2)cc1";"IC50";"'='";"3190.0";"nM";"5.50";"";"";"UO_0000065";"10.73";"0.22";"-0.86";"7.58";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824823";"";"None";"456.35";"1";"5.93";"26";"O=C(NS(=O)(=O)c1ccc2ccccc2c1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"10870.0";"nM";"4.96";"";"";"UO_0000065";"10.88";"0.23";"-0.97";"7.85";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824826";"";"None";"518.46";"2";"6.74";"29";"O=C(NS(=O)(=O)c1ccc(OCC2CCCCC2)cc1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"13.11";"0.27";"0.06";"9.38";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL3126116";"";"None";"657.76";"1";"4.39";"7";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccccc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"10.37";"0.22";"2.43";"5.60";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398290";"";"None";"377.43";"1";"5.01";"6";"Cc1c(C(=O)O)cccc1-c1ccc(/C=N/Nc2nc3ccccc3s2)o1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.45";"0.24";"-0.31";"5.36";"0";"CHEMBL2399243";"Displacement of biotinylated-Bim from Bcl-Xl (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398292";"";"None";"377.43";"1";"5.09";"12a";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(=O)O)c2)o1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"12.78";"0.24";"-0.27";"5.50";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398287";"";"None";"388.45";"0";"4.89";"41";"C/C(=N\Nc1nc2ccccc2s1)c1cccc(-c2cncc(C(=O)O)c2)c1";"IC50";"'='";"8100.0";"nM";"5.09";"";"";"UO_0000065";"13.11";"0.25";"0.20";"5.82";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398173";"";"None";"414.49";"1";"5.21";"59b";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"18.57";"0.35";"2.49";"8.80";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3703602";"";"None";"975.57";"3";"7.62";"BDBM156382";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN(CCO)CCO)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"363098";"UO_0000065";"9.23";"0.19";"1.38";"5.10";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703608";"";"None";"944.56";"3";"8.22";"BDBM156388";"CN(CCO)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](N)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"3.0";"nM";"8.52";"";"363104";"UO_0000065";"9.02";"0.18";"0.30";"5.26";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3704829";"";"None";"642.70";"3";"7.98";"BDBM174845";"Cc1ccc(CC(=O)c2c(O)c(O)cc3c(O)c(-c4c(C)cc5c(C(=O)Cc6ccc(C)cc6)c(O)c(O)cc5c4O)c(C)cc23)cc1";"IC50";"'='";"320.0";"nM";"6.50";"";"320215";"UO_0000065";"10.11";"0.18";"-1.49";"4.18";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3963735";"";"None";"1058.48";"None";"None";"BDBM232436";"CCCCN(Cc1ccc(-c2ccc(CC(=O)O)cc2)cc1)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4Cc3ccc(Cl)c(Cl)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"80.0";"nM";"7.10";"";"405334";"UO_0000065";"6.70";"None";"None";"None";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927294";"";"None";"867.42";"2";"9.97";"BDBM232441";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1ccc(Oc2cccc(Cl)c2)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"405340";"UO_0000065";"8.33";"0.16";"-2.75";"5.28";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912906";"";"None";"705.88";"2";"6.60";"BDBM232445";"CCCCN(CCCC)C(=O)c1cn(C)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"40.0";"nM";"7.40";"";"405350";"UO_0000065";"10.48";"0.20";"0.80";"6.08";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2031009";"";"None";"746.72";"2";"6.91";"BDBM50384340";"CCCN(CCC)c1ncc(Cl)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"405360";"UO_0000065";"10.71";"0.21";"1.09";"6.02";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL373631";"";"None";"717.89";"2";"7.06";"10b";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4F)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"8.53";"0.17";"-0.94";"4.90";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376921";"";"None";"702.90";"2";"5.56";"23a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"9.18";"0.18";"0.90";"5.04";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL217960";"";"None";"796.99";"2";"7.37";"23q";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"4";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"'='";"190000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1107439";"Displacement of FITC-conjugated BH3-Bak peptide from human recombinant Bcl-XL expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157820";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL4218405";"";"None";"999.64";"3";"9.18";"28";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CNC2(Cn3cnc4cc(C(=O)NS(=O)(=O)c5ccc(N[C@H](CCN6CCOCC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)ccc43)CC2)C1";"IC50";"'='";"29.3";"nM";"7.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4208633";"";"None";"906.49";"2";"6.98";"52";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@@H](CC5CC5)C(=O)N5CCOCC5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"59.3";"nM";"7.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3342187";"";"None";"583.74";"2";"6.74";"24; WEHI-539";"NCc1ccc(OCCCc2sc(-c3ccc4c(c3)/C(=N/Nc3nc5ccccc5s3)CCC4)nc2C(=O)O)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.35";"0.30";"2.22";"7.30";"0";"CHEMBL4052854";"Inhibition of biotinylated BIM BH3 26-mer peptide binding to GST-tagged Bcl-xL (unknown origin) pre-incubated for 30 mins followed by peptide addition measured after 4 hrs by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL2063884";"";"None";"1090.77";"None";"None";"8, BM-908";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(-c3cn(-c4cccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)c4)nn3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"7.63";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063885";"";"None";"1075.75";"None";"None";"9, BM-593";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(C#Cc3cccc(-c4c(-c5ccc(Cl)cc5)cn(CC[C@H](O)CO)c4C(=O)NCCCN4CCN(C)CC4)c3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"7.66";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063887";"";"None";"1081.81";"None";"None";"11, BM-987";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(NCCNc3cccc(-c4c(-c5ccc(Cl)cc5)cn(CC[C@H](O)CO)c4C(=O)NCCCN4CCN(C)CC4)c3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"44.1";"nM";"7.36";"";"";"UO_0000065";"6.80";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2326745";"";"None";"928.57";"3";"8.44";"10";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"8.21";"0.17";"-0.82";"5.96";"0";"CHEMBL2328209";"Inhibition of Bcl-xL/BAK (unknown origin) interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321763";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2159738";"";"None";"864.54";"2";"9.88";"7";"Cc1cc(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"9.21";"0.18";"-1.92";"6.86";"1";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL538616";"";"None";"700.79";"3";"7.58";"8r";"Cc1cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"8.73";"0.16";"-1.46";"3.41";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL4207006";"";"None";"895.46";"3";"6.27";"54";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5(CN6CCOCC6)COC5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"49.3";"nM";"7.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3899842";"";"None";"975.57";"3";"7.62";"BDBM156382";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN(CCO)CCO)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"298860";"UO_0000065";"9.23";"0.19";"1.38";"5.10";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL374214";"";"None";"734.34";"2";"7.58";"10d";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"8.57";"0.17";"-1.29";"5.04";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL385101";"";"None";"717.89";"2";"7.06";"10a";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccc(F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"8.75";"0.17";"-0.78";"5.03";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2063897";"";"None";"922.57";"3";"9.83";"6";"CCc1c(-c2ccc(Cl)cc2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(C(=O)O)n1C";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"8.81";"0.17";"-1.71";"5.30";"1";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3287287";"";"None";"429.50";"1";"5.12";"6a";"O=C(O)c1cccc(-c2ccc3c(c2)C(C(=O)Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"9600.0";"nM";"5.02";"";"";"UO_0000065";"11.68";"0.22";"-0.10";"5.44";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL426535";"";"None";"766.39";"2";"7.12";"8f";"COC1(Cc2ccccc2Cl)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"9.40";"0.19";"0.09";"5.37";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2030866";"";"None";"710.30";"2";"7.67";"4b";"CCCCN(CCCC)c1nccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"8.90";"0.17";"-1.35";"5.61";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030853";"";"None";"825.39";"2";"9.29";"3j";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2cccc(Cl)c2)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"9.38";"0.18";"-1.55";"5.92";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL379173";"";"None";"577.53";"1";"4.33";"8, MI-63";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866346";"Displacement of Flu-Bid from human recombinant Bcl-xL receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148527";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1269073";"";"None";"570.64";"2";"6.07";"BDBM142751";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CC3CCCC3)C2=O)C(=O)c2cc(O)c(O)c(CC3CCCC3)c2C1=O";"IC50";"'='";"2990.0";"nM";"5.52";"";"278893";"UO_0000065";"9.68";"0.18";"-0.55";"3.70";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1269070";"";"None";"728.75";"3";"5.67";"BDBM142746";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(=O)NCC(C)c3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(C(=O)NCC(C)c3ccccc3)c2C1=O";"IC50";"'='";"320.0";"nM";"6.50";"";"278899";"UO_0000065";"8.91";"0.16";"0.82";"3.13";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3393633";"";"None";"690.37";"2";"6.65";"23";"O=C(O)CSc1ccc(C(=O)c2[nH]c(Cl)c(Cl)c2-n2c(C(=O)c3ccc(SCC(=O)O)cc3O)cc(Cl)c2Cl)c(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147754";"Inhibition of biotin labelled Bid-BH3 binding to GST-tagged BCL-XL (unknown origin) preincubated for 15 mins followed by biotin labelled Bid-BH3 addition measured after 2 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145520";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3393621";"";"None";"510.16";"2";"6.29";"Marinopyrrole A";"O=C(c1ccccc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccccc2O)cc(Cl)c1Cl";"IC50";"'>'";"80000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4147747";"Inhibition of biotin labelled Bid-BH3 binding to C-terminal GST-tagged human BCL-XL transmembrane domain expressed in Escherichia coli BL21 (DE3) preincubated for 1 hr followed by followed by biotin labelled Bid-BH3 addition measured after 2 hrs by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145520";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3921948";"";"None";"957.56";"3";"8.66";"BDBM156392";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"298870";"UO_0000065";"9.40";"0.19";"0.34";"6.19";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL602758";"";"None";"332.32";"0";"3.01";"4, BI21-C5";"N#Cc1c(-c2ccc3c(c2)OCO3)cc(-c2ccccc2O)[nH]c1=O";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"15.93";"0.29";"2.28";"5.55";"0";"CHEMBL1072273";"Displacement of biotinylated-BH3 peptide from Bcl-xL by TR-FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157656";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2030860";"";"None";"727.89";"2";"6.17";"3q";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)c(CO)nn1-c1ccccc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"11.20";"0.21";"1.98";"5.52";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031020";"";"None";"904.32";"2";"8.70";"20";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4C(=O)c3ccc(Cl)c(Cl)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"6.92";"0.14";"-2.44";"4.41";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031032";"";"None";"741.31";"2";"7.17";"38";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CNc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"10.23";"0.20";"0.42";"5.67";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL4560892";"";"None";"744.84";"3";"5.06";"12";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)c(S(=O)(=O)O)c1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"8.67";"0.18";"1.40";"3.48";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3703617";"";"None";"1042.71";"None";"None";"BDBM156398";"CCN(CC)C[C@@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"0.5";"nM";"9.30";"";"298876";"UO_0000065";"8.92";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL408194";"OBATOCLAX";"3.0";"317.39";"0";"4.49";"GX015-070";"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C";"IC50";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"16.79";"0.30";"0.84";"10.02";"1";"CHEMBL4147763";"Inhibition of Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145520";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3899315";"";"None";"957.56";"3";"8.66";"BDBM156391";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"78.0";"nM";"7.11";"";"298869";"UO_0000065";"7.42";"0.15";"-1.55";"4.89";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3193581";"";"None";"423.86";"0";"4.16";"SID49824139";"C/C(=N\NC(=O)c1cc(O)ccc1O)c1cccc(NC(=O)c2ccc(Cl)cc2)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1597177";"";"None";"330.14";"0";"4.26";"SID4263768";"Oc1ccc2cc3c4cc(Br)ccc4nc-3oc2c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1345135";"";"None";"343.39";"0";"4.76";"SID7977755";"Cc1ccc(NC(=O)c2cc(-c3ccc(C)o3)nc3ccccc23)nc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1543134";"";"None";"338.32";"0";"2.91";"SID49828250";"O=C(CNC(=O)/C=C/c1ccco1)N=Nc1c(O)[nH]c2ccccc12";"IC50";"'='";"37072.0";"nM";"4.43";"";"Not Active";"UO_0000065";"13.10";"0.24";"1.52";"3.69";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1449253";"";"None";"375.48";"0";"3.39";"SID7967482";"COc1ccc(Cc2nnc(NC(=O)Cc3cccs3)s2)cc1OC";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL11875";"";"None";"289.32";"0";"2.21";"SID47199153";"Nc1ccc(S(=O)(=O)Nc2nc3ccccc3o2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1451039";"";"None";"299.25";"0";"3.12";"SID47194045";"O=C(O)C1Nc2ccc(OC(F)(F)F)cc2C2C=CCC12";"IC50";"'='";"60566.0";"nM";"4.22";"";"Not Active";"UO_0000065";"14.09";"0.27";"1.10";"7.20";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427879";"";"None";"347.40";"0";"2.40";"SID7977412";"CCOC(=O)c1ccc(NC(=O)CSc2nc(C)cc(O)n2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3189416";"";"None";"409.45";"1";"5.31";"SID14720692";"Nc1ccc(C(=O)N/N=C\c2cc(N=Nc3cccc4ccccc34)ccc2O)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL458328";"";"None";"296.41";"0";"4.01";"SID855627";"CCCCCC#CCC#CCC#CCC#CCCCC(=O)O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1318277";"";"None";"442.90";"0";"3.72";"SID57265871";"O=C(O)/C(=C\c1ccc(Cl)c([N+](=O)[O-])c1)c1ccc(S(=O)(=O)N2CCCC2)s1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3193176";"";"None";"347.37";"0";"3.10";"SID17504889";"O=C(CNc1cccc2ccccc12)N/N=C/c1ccc(C(=O)O)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1311053";"";"None";"447.55";"0";"4.45";"SID24789389";"CCc1sc(C(C2C(=O)CC(C)(C)CC2=O)C2C(=O)CC(C)(C)CC2=O)cc1[N+](=O)[O-]";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1408747";"";"None";"425.47";"0";"2.83";"SID49725372";"O=C(O)c1ccc(-n2cccc2/C=C2/SC(=O)N(CC(=O)N3CCCC3)C2=O)cc1";"IC50";"'='";"103947.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL375299";"";"None";"788.01";"3";"5.40";"23g";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4N4CCOCC4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3916642";"";"None";"1042.71";"None";"None";"BDBM156403";"CCN(CC)CC1CN(CC[C@@H](CSc2ccccc2)Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC([C@H](O)c5ccccc5-c5ccc(Cl)cc5)CC4)cc3)cc2S(=O)(=O)C(F)(F)F)CCO1";"IC50";"'='";"0.5";"nM";"9.30";"";"298881";"UO_0000065";"8.92";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1272170";"";"None";"490.51";"0";"4.85";"BDBM142745";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O";"IC50";"'='";"630.0";"nM";"6.20";"";"278889";"UO_0000065";"12.64";"0.24";"1.35";"4.16";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1269110";"";"None";"655.49";"2";"7.09";"6l";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccc(Cl)cc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccc(Cl)cc3)c2C1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"10.41";"0.20";"-0.27";"4.57";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL553474";"";"None";"741.62";"3";"7.76";"8p";"Cc1cc2c(C(=O)NCCc3cccc(Cl)c3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCCc3cccc(Cl)c3)c(O)c(O)cc2c1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2398271";"";"None";"391.45";"1";"5.02";"17b";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(CC(=O)O)c2)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1689142";"";"None";"966.57";"3";"8.66";"30";"O=S(=O)(Nc1ncnc2cc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)ccc12)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"8.07";"0.16";"-0.86";"5.69";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2030856";"";"None";"742.90";"2";"6.38";"3m";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(CCO)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"11.07";"0.21";"1.84";"5.80";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3287283";"";"None";"420.52";"1";"5.27";"2";"O=C(O)c1csc(-c2ccc3c(c2)/C(=N/Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.75";"0.37";"2.62";"9.02";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311329";"";"None";"942.55";"3";"8.04";"1";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"8.27";"0.17";"-0.24";"6.07";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4861424";"";"None";"902.01";"3";"9.03";"17e";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccccc2C(F)(F)F)C1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"7.43";"0.14";"-2.33";"3.89";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4852442";"";"None";"917.07";"3";"9.33";"24b";"CCN(CC)CCCNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(C(F)(F)F)cc5)CC(C)(C)CC4)CC3)cc2Oc2cnc3[nH]ccc3c2)cc1[N+](=O)[O-]";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"8.29";"0.16";"-1.73";"4.58";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4860155";"";"None";"873.96";"3";"8.39";"24f";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NC5CCOC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'='";"837.4";"nM";"6.08";"";"";"UO_0000065";"6.95";"0.13";"-2.31";"3.53";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL373577";"";"None";"697.92";"2";"6.27";"8a";"COC1(CC(C)C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"9.23";"0.18";"0.17";"4.80";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL375841";"";"None";"766.39";"2";"7.12";"8h";"COC1(Cc2ccc(Cl)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"8.74";"0.18";"-0.42";"4.99";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1095311";"";"None";"578.62";"2";"5.56";"12j";"COC1CC2=C(N=c3s/c(=C\c4ccc(-c5cccc(C(=O)O)c5)o4)c(=O)n3C2c2cccc(F)c2)c2ccccc21";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2030852";"";"None";"825.39";"2";"9.29";"3i";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2ccc(Cl)cc2)cc1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"9.03";"0.17";"-1.83";"5.70";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031004";"";"None";"740.33";"2";"7.03";"4f";"CCCCN(CCCC)c1nccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"9.30";"0.18";"-0.14";"5.19";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031005";"";"None";"710.30";"2";"7.67";"4g";"CCCCN(CCCC)c1ncc(Cl)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"9.35";"0.18";"-1.03";"5.90";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL221856";"";"None";"800.06";"3";"7.30";"23f";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4NC4CCCCC4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"8.04";"0.16";"-0.87";"4.59";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL387142";"";"None";"716.93";"2";"5.87";"23b";"Cc1ccccc1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.56";"0.19";"0.98";"5.35";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2442249";"";"None";"449.90";"1";"5.34";"9";"CCN1CCN(C(c2ccc(C(F)(F)F)cc2)c2cc(Cl)c3cccnc3c2O)CC1";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2445381";"Inhibition of human GST-tagged Bcl-xL expressed in Escherichia coli BL21 using FITC-AHA-MRPEIWIAQELRRIGDEFNA-[NH2] after 20 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439986";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL1990772";"";"None";"372.38";"0";"3.35";"SID14746067";"C/C(=N/NC(=O)c1cc2ccccc2cc1O)C1C(=O)c2ccccc2C1=O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1336615";"";"None";"378.21";"0";"4.07";"SID24791527";"O=c1nc(Nc2ccc(Br)cc2)sc2ccc([N+](=O)[O-])cc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL541427";"";"None";"696.76";"3";"6.30";"8s";"Cc1cc2c(C(=O)NC3Cc4ccccc4C3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC3Cc4ccccc4C3)c(O)c(O)cc2c1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL554545";"";"None";"728.84";"3";"8.22";"8j";"Cc1cc(C)c(CNC(=O)c2c(O)c(O)cc3c(O)c(-c4c(C)cc5c(C(=O)NCc6c(C)cc(C)cc6C)c(O)c(O)cc5c4O)c(C)cc23)c(C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3917011";"";"None";"956.58";"3";"8.63";"BDBM156410";"N[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"298885";"UO_0000065";"7.82";"0.16";"-1.15";"4.95";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3900017";"";"None";"1013.63";"None";"None";"BDBM156412";"NCC(=O)N[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"298887";"UO_0000065";"7.55";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3265288";"";"None";"347.44";"0";"3.09";"MIM1";"Cc1cs/c(=N\C2CCCCC2)n1/N=C/c1ccc(O)c(O)c1O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3266890";"Displacement of Flu-BID/FAM-BID from His-tagged BCLX-L (1 to 209) (unknown origin) expressed in Escherichia coli BL21(DE3) after 3 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259780";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3703605";"";"None";"1039.55";"None";"None";"BDBM156385";"CCN(CCOP(=O)(O)O)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"363101";"UO_0000065";"8.66";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703612";"";"None";"957.56";"3";"8.66";"BDBM156392";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"363108";"UO_0000065";"9.40";"0.19";"0.34";"6.19";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703615";"";"None";"966.57";"3";"9.24";"BDBM156396";"N#C[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"363112";"UO_0000065";"8.38";"0.17";"-1.14";"5.44";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4108604";"";"None";"1014.65";"None";"None";"BDBM204936";"CN(C)C[C@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"363113";"UO_0000065";"8.87";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703619";"";"None";"987.58";"3";"8.03";"BDBM156400";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCO[C@H](CO)C2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"363116";"UO_0000065";"9.11";"0.19";"0.97";"5.44";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703629";"";"None";"984.63";"3";"9.23";"BDBM156413";"CN(C)[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"363126";"UO_0000065";"7.87";"0.16";"-1.49";"6.03";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931032";"";"None";"1051.57";"None";"None";"BDBM156407";"COP(=O)(O)O[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"298884";"UO_0000065";"8.56";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3914542";"";"None";"846.45";"2";"8.93";"BDBM232386";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OCc5ccccc5)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"30.0";"nM";"7.52";"";"405276";"UO_0000065";"8.89";"0.17";"-1.41";"5.75";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1689140";"";"None";"879.51";"3";"8.28";"28";"O=[N+]([O-])c1cc(S(=O)(=O)Nc2ncnc3cc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc23)ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"8.49";"0.17";"-0.81";"5.11";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL3703618";"";"None";"987.58";"3";"8.03";"BDBM156399";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCO[C@@H](CO)C2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"363115";"UO_0000065";"8.63";"0.18";"0.49";"5.15";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703622";"";"None";"1042.71";"None";"None";"BDBM156403";"CCN(CC)CC1CN(CC[C@H](CSc2ccccc2)Nc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC([C@@H](O)c5ccccc5-c5ccc(Cl)cc5)CC4)cc3)cc2S(=O)(=O)C(F)(F)F)CCO1";"IC50";"'='";"0.5";"nM";"9.30";"";"363119";"UO_0000065";"8.92";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703623";"";"None";"1123.67";"None";"None";"BDBM156405";"CC(C)(C)OP(=O)(O)OCO[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"363120";"UO_0000065";"7.74";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL541004";"";"None";"656.78";"3";"7.13";"8m";"Cc1cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c1O";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"9.24";"0.17";"-1.06";"3.38";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"6";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"12.19";"0.23";"-0.06";"4.06";"0";"CHEMBL1072271";"Inhibition of Bcl-xL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157656";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3311479";"";"None";"944.52";"3";"6.83";"4";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)nn1";"IC50";"'='";"378.0";"nM";"6.42";"";"";"UO_0000065";"6.80";"0.14";"-0.41";"4.17";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311486";"";"None";"955.54";"3";"8.81";"11";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC(C(=O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2063888";"";"None";"1107.84";"None";"None";"12";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4ccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"7.33";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1319129";"";"None";"344.44";"0";"2.96";"SID56323176";"COc1ccc(NC(=O)CN(C)C(=O)c2cc3c(s2)CCC3)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1459125";"";"None";"335.39";"0";"4.51";"SID17515923";"Cc1csc(NC(=O)c2cc(-c3ccco3)nc3ccccc23)n1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1964442";"";"None";"246.22";"0";"1.45";"SID49825935";"O=C(N/N=C/c1ccoc1)c1cc(O)cc(O)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2031009";"";"None";"746.72";"2";"6.91";"4k";"CCCN(CCC)c1ncc(Cl)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"10.77";"0.22";"1.14";"6.06";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031007";"";"None";"647.80";"2";"6.24";"4i";"CCCN(CCC)c1nccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"10.19";"0.19";"0.36";"5.86";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1269072";"";"None";"642.62";"2";"5.45";"7";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(=O)Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(C(=O)Cc3ccccc3)c2C1=O";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"10.07";"0.18";"1.02";"3.53";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269075";"";"None";"614.65";"2";"6.17";"6e";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(CCc3ccccc3)c2C1=O";"IC50";"'='";"1790.0";"nM";"5.75";"";"";"UO_0000065";"9.35";"0.17";"-0.42";"3.85";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269076";"";"None";"642.70";"2";"6.79";"6f";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCc3ccc(C)cc3)C2=O)C(=O)c2cc(O)c(O)c(CCc3ccc(C)cc3)c2C1=O";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"8.57";"0.16";"-1.28";"3.69";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3704831";"";"None";"782.64";"3";"9.16";"BDBM174847";"Cc1cc2c(C(=O)Cc3ccc(OC(F)(F)F)cc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)Cc3ccc(OC(F)(F)F)cc3)c(O)c(O)cc2c1O";"IC50";"'='";"1300.0";"nM";"5.89";"";"320217";"UO_0000065";"7.52";"0.14";"-3.27";"3.38";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2063895";"";"None";"922.57";"3";"9.75";"19";"CCOC(=O)c1c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)cn1C";"IC50";"'='";"12.6";"nM";"7.90";"";"";"UO_0000065";"8.56";"0.17";"-1.85";"5.55";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063896";"";"None";"894.52";"3";"9.27";"20";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(C)c5C(=O)O)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"9.44";"0.19";"-0.83";"5.51";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1824811";"";"None";"511.52";"2";"6.07";"15";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1cccc(-c2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"10.18";"0.20";"-0.86";"7.19";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824812";"";"None";"512.41";"2";"6.36";"16";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1cccc(-c2cc(Cl)cc(Cl)c2)c1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"12.70";"0.26";"0.15";"8.98";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1518374";"";"None";"459.46";"0";"3.23";"SID14745657";"O=C(OCC(=O)N1CCN(C(=O)c2ccco2)CC1)c1cc(-c2ccco2)nc2ccccc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL339835";"";"None";"248.19";"0";"1.01";"1142";"O=C(O)c1cc(O)c(=O)c2cc(O)c(O)cc2c1";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"20.67";"0.39";"4.12";"4.46";"0";"CHEMBL647263";"Inhibitory concentration against Bcl-xl";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144902";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL1824816";"";"None";"429.50";"1";"5.26";"19";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1cccc(-c2ccccc2)c1";"IC50";"'='";"28520.0";"nM";"4.54";"";"";"UO_0000065";"10.58";"0.20";"-0.72";"6.27";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1601742";"";"None";"429.42";"0";"3.92";"SID49646496";"CCOC(=O)C[C@H]1c2ccc(C(F)(F)F)cc2S(=O)(=O)N1c1cccc(OC)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4279038";"";"None";"952.02";"3";"7.47";"28a";"C[C@@H]1CC[C@H]2C(CN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)=C(C(F)(F)F)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32O4";"IC50";"'='";"970.0";"nM";"6.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1824815";"";"None";"512.41";"2";"6.36";"18";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"7150.0";"nM";"5.15";"";"";"UO_0000065";"10.04";"0.21";"-1.21";"7.10";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824828";"";"None";"557.84";"2";"7.10";"31";"N#Cc1c(Cl)cccc1Oc1ccc(S(=O)(=O)NC(=O)c2cccc(-c3ccc(Cl)c(Cl)c3)c2)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"9.98";"0.21";"-1.53";"5.78";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1096755";"";"None";"548.60";"2";"5.42";"12c";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3cccc(F)c3)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.07";"0.19";"0.10";"6.51";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1095758";"";"None";"520.57";"1";"4.87";"12g";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3ccco3)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"35900.0";"nM";"4.45";"";"";"UO_0000065";"8.54";"0.16";"-0.43";"4.54";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2312474";"";"None";"410.52";"1";"6.20";"8b";"CCCCNC1=C2C(=NC1=O)c1cccc3c(Oc4ccc(C(C)C)cc4)ccc2c13";"IC50";"'='";"283.0";"nM";"6.55";"";"";"UO_0000065";"15.95";"0.29";"0.35";"12.92";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL1580684";"";"None";"582.48";"1";"2.89";"SID49815818";"O=C(CN1C(=O)/C(=C2\SC(=S)N(CCS(=O)(=O)O)C2=O)c2ccccc21)Nc1cccc(Br)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL469424";"ASTERRIC ACID";"None";"348.31";"0";"2.69";"SID26725096";"COC(=O)c1cc(O)cc(OC)c1Oc1cc(C)cc(O)c1C(=O)O";"IC50";"'='";"54218.0";"nM";"4.27";"";"Not Active";"UO_0000065";"12.25";"0.23";"1.58";"3.48";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3704825";"";"None";"570.64";"3";"7.26";"BDBM174841";"Cc1cc2c(C(=O)C3CCCC3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)C3CCCC3)c(O)c(O)cc2c1O";"IC50";"'='";"450.0";"nM";"6.35";"";"320211";"UO_0000065";"11.12";"0.21";"-0.91";"4.08";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704828";"";"None";"722.59";"3";"9.01";"BDBM174844";"Cc1cc2c(C(=O)c3ccc(C(F)(F)F)cc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)c3ccc(C(F)(F)F)cc3)c(O)c(O)cc2c1O";"IC50";"'='";"250.0";"nM";"6.60";"";"320214";"UO_0000065";"9.14";"0.17";"-2.41";"4.25";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1689139";"";"None";"837.47";"3";"8.51";"21";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3cc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc23)cc1[N+](=O)[O-]";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"9.74";"0.19";"-0.36";"5.96";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1689143";"";"None";"869.56";"3";"9.30";"31";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3cc(N4CCN(CC5=C(c6ccc(Cl)cc6)CCC(C)(C)C5)CC4)ccc23)cc1[N+](=O)[O-]";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"9.80";"0.19";"-0.78";"6.23";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL218408";"";"None";"813.45";"2";"7.88";"23o";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4cccc(Cl)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"8.43";"0.17";"-1.03";"5.35";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1095309";"";"None";"560.63";"2";"5.29";"12h";"COc1ccc(C2C3=C(N=c4s/c(=C\c5ccc(-c6cccc(C(=O)O)c6)o5)c(=O)n42)c2ccccc2CC3)cc1";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"9.16";"0.17";"-0.15";"5.46";"0";"CHEMBL1120824";"Displacement of FITC-labeled BH3 peptide from human Bcl-XL after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3311480";"";"None";"944.52";"3";"6.83";"5";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1cnc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)nc1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"7.84";"0.16";"0.58";"4.81";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311483";"";"None";"975.51";"3";"8.22";"8";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(P2(=O)CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"308.0";"nM";"6.51";"";"";"UO_0000065";"6.67";"0.14";"-1.71";"4.58";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2396672";"";"None";"389.44";"1";"5.21";"26";"O=C(O)c1cccc(-c2ccc(/C=N/Nc3ncc(-c4ccccc4)s3)o2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3309311";"";"None";"1043.65";"None";"None";"25";"CN(C)C(=O)COc1cccc(-c2ccc(Cl)cc2)c1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"226.0";"nM";"6.65";"";"";"UO_0000065";"6.37";"None";"None";"None";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2030844";"";"None";"698.80";"2";"6.49";"3a";"CCOC(=O)c1nn(-c2ccccc2)c(C)c1-c1ccc(C(=O)NS(=O)(=O)c2ccc3ccccc3c2)cc1C(=O)N1CCc2ccccc2C1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"8.86";"0.17";"-0.30";"4.85";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3287289";"";"None";"415.43";"0";"3.96";"8";"O=C(O)c1cccc(-c2ccc3ncc(C(=O)Nc4nc5ccccc5s4)n3c2)n1";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"12.70";"0.24";"1.32";"4.82";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3922113";"";"None";"987.59";"3";"8.03";"BDBM156401";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCOC[C@@H]2CO)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"298879";"UO_0000065";"8.81";"0.18";"0.67";"5.25";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3931799";"";"None";"966.57";"3";"9.24";"BDBM156394";"N#C[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"298872";"UO_0000065";"9.31";"0.19";"-0.24";"6.04";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2325774";"";"None";"851.50";"3";"8.97";"20";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5cnn(C)c5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"9.19";"0.18";"-1.15";"6.07";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1269012";"";"None";"756.81";"3";"5.67";"8c";"CCc1ccc(CCNC(=O)c2c(O)c(O)cc3c2C(=O)C(C)=C(C2=C(C)C(=O)c4c(cc(O)c(O)c4C(=O)NCCc4ccc(CC)cc4)C2=O)C3=O)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"8.75";"0.16";"0.95";"3.19";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269073";"";"None";"570.64";"2";"6.07";"6c";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CC3CCCC3)C2=O)C(=O)c2cc(O)c(O)c(CC3CCCC3)c2C1=O";"IC50";"'='";"2990.0";"nM";"5.52";"";"";"UO_0000065";"9.68";"0.18";"-0.55";"3.70";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"SID11114252";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"12.19";"0.23";"-0.06";"4.06";"1";"CHEMBL1106536";"Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157826";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL538616";"";"None";"700.79";"3";"7.58";"rac-4";"Cc1cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"9.15";"0.17";"-1.17";"3.57";"0";"CHEMBL1106536";"Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157826";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094250";"1,1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMETHYL-N5-((R)-2-PHENYLPROPYL)-N5'-((R)-2-PHENYLPROPYL)-2,2'-BINAPHTHYL-5,5'-DICARBOXAMIDE (ATROPISOMERIC MIX)";"None";"700.79";"3";"7.58";"(R, +, R)-12";"Cc1cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"8.80";"0.16";"-1.41";"3.43";"0";"CHEMBL1106536";"Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157826";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3199065";"";"None";"401.20";"0";"1.19";"SID24786872";"Nc1nnc(CC(=O)N/N=C/c2cc([N+](=O)[O-])cc(Br)c2O)s1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1449334";"";"None";"259.29";"0";"3.11";"SID859770";"CSc1nnc(-c2ccco2)c(-c2ccco2)n1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1419305";"";"None";"316.36";"0";"1.85";"SID17503873";"CC12CCC(C(=O)N(NC(=O)c3ccccc3O)C1=O)C2(C)C";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3989558";"METHYSERGIDE MALEATE";"4.0";"469.54";"0";"1.94";"SID56422124";"CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O";"IC50";"'='";"22633.0";"nM";"4.64";"";"Not Active";"UO_0000065";"13.14";"0.24";"2.71";"8.08";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL119171";"";"None";"299.31";"0";"-1.69";"SID26666854";"Nc1nc(S)c2ncn(C3OC(CO)C(O)C3O)c2n1";"IC50";"'='";"34008.0";"nM";"4.47";"";"Not Active";"UO_0000065";"14.93";"0.31";"6.16";"3.20";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1397359";"";"None";"367.34";"0";"1.86";"SID57259953";"COc1ccc(C(=O)OCC(=O)Nc2ncc([N+](=O)[O-])s2)cc1OC";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1315784";"";"None";"472.50";"0";"3.33";"SID51087844";"O=S(=O)(c1cc(O)ccc1O)c1cccc2c(S(=O)(=O)c3cc(O)ccc3O)cccc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3963300";"";"None";"866.53";"2";"7.40";"BDBM232412";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CNC2CCN(C)CC2)c(C)c1Cl";"IC50";"'='";"7.06";"nM";"8.15";"";"405309";"UO_0000065";"9.41";"0.18";"0.75";"5.95";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3287286";"";"None";"415.52";"1";"5.59";"5b, enantiomer";"O=C(O)c1cccc(-c2ccc3c(c2)C(CNc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"9200.0";"nM";"5.04";"";"";"UO_0000065";"12.12";"0.23";"-0.55";"6.71";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3287299";"";"None";"546.65";"2";"6.46";"20";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(/C=C/Cc3ccccc3)c(C(=O)O)n1)CC2";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.36";"0.29";"1.94";"8.80";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1824803";"";"None";"461.51";"1";"5.19";"8";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'='";"9370.0";"nM";"5.03";"";"";"UO_0000065";"10.90";"0.21";"-0.16";"6.94";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824806";"";"None";"429.50";"1";"5.26";"11";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1ccc(-c2ccccc2)cc1";"IC50";"'='";"28030.0";"nM";"4.55";"";"";"UO_0000065";"10.60";"0.20";"-0.71";"6.28";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2031022";"";"None";"890.33";"2";"9.06";"BDBM50384353";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4Cc3ccc(Cl)c(Cl)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405293";"UO_0000065";"8.31";"0.17";"-1.66";"5.92";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898017";"";"None";"784.34";"2";"7.05";"BDBM232410";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccc(C(=O)O)cc3C2)c(C)c1Cl";"IC50";"'='";"3510.0";"nM";"5.46";"";"405306";"UO_0000065";"6.95";"0.14";"-1.60";"3.43";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3311490";"";"None";"966.57";"3";"9.07";"16";"N#CC1(Cc2ccccc2-c2ccc(Cl)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"2820.0";"nM";"5.55";"";"";"UO_0000065";"5.74";"0.12";"-3.52";"3.73";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL66953";"PURPUROGALLIN";"None";"220.18";"0";"1.02";"Purpurogallin";"O=c1c(O)cccc2cc(O)c(O)c(O)c12";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"25.70";"0.48";"4.64";"5.77";"0";"CHEMBL647263";"Inhibitory concentration against Bcl-xl";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144902";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL3287294";"";"None";"534.64";"2";"5.99";"15";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(CCc3ccccc3)c(C(=O)O)n1)CC2";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"11.62";"0.22";"0.22";"6.51";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3936837";"";"None";"867.51";"2";"8.21";"BDBM232395";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OCCCN5CCCC5)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"30.0";"nM";"7.52";"";"405286";"UO_0000065";"8.67";"0.17";"-0.69";"5.61";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893121";"";"None";"809.22";"2";"8.65";"BDBM232397";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)ccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"30.0";"nM";"7.52";"";"405288";"UO_0000065";"9.30";"0.19";"-1.13";"6.18";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936947";"";"None";"918.34";"2";"8.86";"BDBM232430";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(ccn4Cc4ccc(Cl)c(Cl)c4)c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"50.0";"nM";"7.30";"";"405328";"UO_0000065";"7.95";"0.16";"-1.56";"4.97";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962772";"";"None";"749.89";"2";"6.15";"BDBM232448";"CCCCN(CCCC)C(=O)c1cn(CC(=O)O)c(-c2ccc(C(=O)NS(=O)(=O)c3cccc4ccccc34)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"405353";"UO_0000065";"10.03";"0.19";"1.37";"4.73";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1824829";"";"None";"577.83";"2";"7.13";"32";"O=C(NS(=O)(=O)c1ccc(Oc2c(Cl)cccc2[N+](=O)[O-])cc1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"9.86";"0.21";"-1.43";"4.93";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824831";"";"None";"516.38";"2";"6.71";"34";"O=C(NS(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"2870.0";"nM";"5.54";"";"";"UO_0000065";"10.73";"0.22";"-1.17";"7.65";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2159733";"";"None";"465.04";"0";"4.69";"8";"Cc1c(C(=O)NCCCN2CCN(C)CC2)c(-c2ccccc2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"291000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"10.11";"0.20";"0.34";"6.42";"1";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159742";"";"None";"2711.04";"None";"None";"BIM";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2322021";"";"None";"963.01";"3";"9.09";"21";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2nc(Cl)nc3c2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"7.99";"0.17";"-1.39";"6.02";"0";"CHEMBL2328209";"Inhibition of Bcl-xL/BAK (unknown origin) interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321763";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2326746";"";"None";"946.56";"3";"8.58";"18";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4cc(F)ccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"7.53";"0.15";"-1.45";"5.58";"0";"CHEMBL2328209";"Inhibition of Bcl-xL/BAK (unknown origin) interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321763";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3287301";"";"None";"570.70";"2";"6.28";"22";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCOc3ccccc3)s1)CC2";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.77";"0.31";"2.72";"8.60";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3912610";"";"None";"866.28";"2";"7.29";"BDBM232435";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3cc(Br)c4c(ccn4CC)c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"7.88";"nM";"8.10";"";"405333";"UO_0000065";"9.35";"0.20";"0.81";"5.52";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901575";"";"None";"803.81";"2";"7.33";"BDBM232432";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)c(C)c1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"405330";"UO_0000065";"9.95";"0.20";"0.67";"5.42";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931548";"";"None";"868.29";"2";"6.70";"BDBM232433";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3cc(Br)c4c(c3)CCN4CC)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"8.85";"nM";"8.05";"";"405331";"UO_0000065";"9.27";"0.20";"1.35";"5.55";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2325770";"";"None";"962.52";"3";"10.29";"16";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(C(=O)O)c(C(F)(F)F)n(C)c5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"8.54";"0.17";"-2.07";"5.36";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325759";"";"None";"895.51";"3";"8.67";"26";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)nn(C)c5C(=O)O)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"9.19";"0.18";"-0.44";"4.95";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325767";"";"None";"898.98";"2";"10.53";"13";"Cc1c(Cl)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"8.81";"0.18";"-2.61";"6.83";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2159739";"";"None";"922.57";"3";"10.06";"14";"CCn1c(C)c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c1-c1ccc(Cl)cc1";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"8.87";"0.17";"-1.88";"5.34";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159735";"";"None";"1047.79";"None";"None";"10";"Cc1c(C(=O)NCCCN2CCN(C)CC2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"7.68";"None";"None";"None";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1606013";"";"None";"409.49";"0";"2.77";"SID56321568";"CCCCN(C(=O)c1cccc(-n2cccc2)c1)c1c(N)n(CCC)c(=O)[nH]c1=O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1514693";"";"None";"372.70";"0";"3.40";"SID49675370";"C[C@H](NS(=O)(=O)OCC(Cl)(Cl)Cl)C1CC1c1ccccc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3978452";"";"None";"883.51";"2";"7.45";"BDBM232389";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(OCCCN5CCOCC5)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"50.0";"nM";"7.30";"";"405280";"UO_0000065";"8.26";"0.16";"-0.15";"5.09";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927392";"";"None";"827.63";"2";"7.71";"BDBM232434";"CCCN(CCC)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)ccc(Br)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405332";"UO_0000065";"8.94";"0.19";"-0.31";"5.93";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703628";"";"None";"1013.63";"None";"None";"BDBM156412";"NCC(=O)N[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"363125";"UO_0000065";"7.55";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703603";"";"None";"1032.64";"None";"None";"BDBM156383";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCN(C[C@H](O)CF)CC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"363099";"UO_0000065";"8.42";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703604";"";"None";"1135.53";"None";"None";"BDBM156384";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN(CCOP(=O)(O)O)CCOP(=O)(O)O)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"363100";"UO_0000065";"7.93";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL553474";"";"None";"741.62";"3";"7.76";"8p";"Cc1cc2c(C(=O)NCCc3cccc(Cl)c3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCCc3cccc(Cl)c3)c(O)c(O)cc2c1O";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"7.01";"0.14";"-2.56";"2.90";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3980026";"";"None";"1080.61";"None";"None";"BDBM156387";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCN(CCOP(=O)(O)O)CC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"298865";"UO_0000065";"8.33";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL221708";"";"None";"700.89";"2";"6.32";"10i";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccn4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"8.78";"0.17";"-0.17";"4.47";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"1";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL858940";"Inhibitory activity against Bcl-XL in presence of HSA from 1% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL2325758";"";"None";"895.51";"3";"8.67";"25";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(C(=O)O)nn(C)c5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"6.1";"nM";"8.21";"";"";"UO_0000065";"9.17";"0.18";"-0.46";"4.94";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325768";"";"None";"932.53";"2";"10.90";"14";"Cc1c(C(F)(F)F)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"8.46";"0.17";"-3.01";"6.80";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398265";"";"None";"391.45";"1";"5.40";"12h";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(=O)O)c2C)o1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.88";"0.28";"0.42";"6.64";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"9.66";"0.19";"-0.03";"6.13";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3287284";"";"None";"411.49";"1";"5.82";"3";"O=C(O)c1cccc(-c2ccc3cccc(CNc4nc5ccccc5s4)c3c2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3287288";"";"None";"430.49";"1";"5.04";"7";"O=C(O)c1cccc(-c2ccc3c(c2)N(C(=O)Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"14.27";"0.27";"1.10";"6.44";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3287298";"";"None";"532.63";"2";"6.37";"19";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(/C=C/c3ccccc3)c(C(=O)O)n1)CC2";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"13.23";"0.25";"0.68";"7.38";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3287286";"";"None";"415.52";"1";"5.59";"5a";"O=C(O)c1cccc(-c2ccc3c(c2)C(CNc2nc4ccccc4s2)CCC3)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2325769";"";"None";"889.55";"3";"9.75";"15";"Cc1c(C#N)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"9.38";"0.18";"-1.40";"5.97";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1095147";"";"None";"544.63";"1";"4.94";"1c";"O=C(O)COc1cccc(/C=c2\sc3n(c2=O)C(c2cccc4ccccc24)C2=C(N=3)c3ccccc3CC2)c1";"IC50";"'='";"19700.0";"nM";"4.71";"";"";"UO_0000065";"8.64";"0.16";"-0.23";"5.82";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1095759";"";"None";"399.33";"0";"4.41";"15";"CC(C)C(C(=O)O)C1C(=O)/C(=C/c2ccc(Br)cc2)SC1=S";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"13.04";"0.32";"0.80";"9.58";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3704824";"";"None";"658.83";"3";"10.09";"BDBM174840";"CCCCC(CC)CC(=O)c1c(O)c(O)cc2c(O)c(-c3c(C)cc4c(C(=O)CC(CC)CCCC)c(O)c(O)cc4c3O)c(C)cc12";"IC50";"'='";"1290.0";"nM";"5.89";"";"320210";"UO_0000065";"8.94";"0.17";"-4.20";"3.79";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL376659";"";"None";"729.93";"2";"6.93";"10g";"COc1ccccc1C=C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"8.38";"0.16";"-0.81";"4.56";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376410";"";"None";"847.00";"2";"8.25";"23r";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(C(F)(F)F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376409";"";"None";"855.10";"2";"8.89";"23p";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(-c5ccccc5)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"8.19";"0.16";"-1.89";"5.46";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1269110";"";"None";"655.49";"2";"7.09";"BDBM142757";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccc(Cl)cc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccc(Cl)cc3)c2C1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"278897";"UO_0000065";"10.41";"0.20";"-0.27";"4.57";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2325760";"";"None";"895.50";"3";"9.83";"27";"Cc1oc(-c2ccc(Cl)cc2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c1C(=O)O";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"9.30";"0.18";"-1.50";"5.16";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2326038";"";"None";"838.46";"3";"9.22";"22";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5cnoc5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"9.13";"0.18";"-1.56";"5.59";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2312472";"";"None";"442.58";"1";"6.22";"7c";"CCCCCCNC1=C2C(=NC1=O)c1cccc3c(Sc4ccc(OC)cc4)ccc2c13";"IC50";"'='";"181.0";"nM";"6.74";"";"";"UO_0000065";"15.23";"0.29";"0.52";"13.30";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2312483";"";"None";"439.58";"0";"4.67";"5h";"O=C1N=C2C(=C1NCCCc1ccccc1)c1ccc(N3CCSCC3)c3cccc2c13";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"16.76";"0.31";"2.70";"16.48";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2312481";"";"None";"377.51";"0";"3.84";"5c";"CCCCNC1=C2C(=NC1=O)c1cccc3c(N4CCSCC4)ccc2c13";"IC50";"'='";"171.0";"nM";"6.77";"";"";"UO_0000065";"17.93";"0.34";"2.93";"15.14";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL384218";"";"None";"809.03";"3";"7.24";"23m";"COc1ccc(-c2ccccc2CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN(C)C)CSc5ccccc5)c([N+](=O)[O-])c4)cc3)CC2)cc1";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2398262";"";"None";"415.48";"0";"4.60";"74a";"O=C(O)c1ccnc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"15.57";"0.29";"1.87";"6.45";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398268";"";"None";"364.39";"0";"4.91";"16a";"O=[N+]([O-])c1cccc(-c2ccc(/C=N/Nc3nc4ccccc4s3)o2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398173";"";"None";"414.49";"1";"5.21";"59b";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"18.43";"0.35";"2.43";"8.73";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398252";"";"None";"428.52";"1";"5.46";"63d";"CC1C/C(=N/Nc2nc3ccccc3s2)c2cc(-c3cccc(C(=O)O)n3)ccc2C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"18.13";"0.34";"2.31";"8.88";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2031014";"";"None";"869.48";"2";"7.06";"14";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(OCCN5CCOCC5)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"8.50";"0.17";"0.33";"5.15";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2398274";"";"None";"490.77";"1";"6.51";"22c";"C/C(=N\Nc1nc2ccc(Br)cc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'='";"9300.0";"nM";"5.03";"";"";"UO_0000065";"10.25";"0.24";"-1.48";"5.74";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398298";"";"None";"421.43";"0";"4.79";"12g";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cc(C(=O)O)cc(C(=O)O)c2)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398267";"";"None";"392.44";"0";"4.67";"12j";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc(N)c(C(=O)O)c2)o1";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"13.18";"0.25";"0.50";"4.55";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398294";"";"None";"377.43";"1";"5.09";"12c";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccccc2C(=O)O)o1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"13.78";"0.26";"0.11";"5.93";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398273";"";"None";"446.32";"1";"6.40";"22b";"C/C(=N\Nc1nc2ccc(Cl)cc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"10.69";"0.22";"-1.63";"5.44";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398260";"";"None";"420.52";"1";"5.27";"71a";"O=C(O)c1csc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"18.75";"0.37";"2.62";"9.02";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL221855";"";"None";"749.00";"3";"6.28";"23d";"CSc1ccccc1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"2, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3126119";"";"None";"887.05";"3";"8.72";"10";"Cc1cc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)ccc1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)nn12";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"9.42";"0.18";"-0.36";"4.51";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325763";"";"None";"999.68";"3";"9.05";"31, BM-1075";"CCn1c(C)c(C(=O)NS(C)(=O)=O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c1-c1ccc(Cl)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"8.16";"0.16";"-0.90";"4.55";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2159740";"";"None";"936.60";"3";"10.62";"28";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"8.88";"0.17";"-2.30";"5.43";"1";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325766";"";"None";"985.65";"3";"8.57";"12";"Cc1c(C(=O)NS(C)(=O)=O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"8.42";"0.17";"-0.27";"4.63";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325765";"";"None";"977.65";"3";"9.09";"11";"Cc1c(C(=O)N2CC(C)(O)C2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"9.4";"nM";"8.03";"";"";"UO_0000065";"8.21";"0.16";"-1.06";"5.13";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2159736";"";"None";"921.59";"3";"9.24";"8";"CNC(=O)c1c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n(C)c1C";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"8.92";"0.18";"-1.02";"5.67";"1";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1094444";"";"None";"498.56";"0";"3.47";"1i";"COc1ccccc1C1C=C(c2ccccc2)N=c2s/c(=C\c3cccc(OCC(=O)O)c3)c(=O)n21";"IC50";"'='";"72000.0";"nM";"4.14";"";"";"UO_0000065";"8.31";"0.16";"0.67";"4.60";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2159740";"";"None";"936.60";"3";"10.62";"28";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C(C)C";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"8.88";"0.17";"-2.30";"5.43";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2031003";"";"None";"704.90";"2";"6.35";"4e";"CCCCN(CCCC)c1nccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)n1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"9.64";"0.18";"0.45";"4.90";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031027";"";"None";"769.37";"2";"6.67";"30";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)c(C)c1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"10.40";"0.20";"1.33";"5.42";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030854";"";"None";"770.95";"2";"8.02";"3k";"CCCCOc1ccc(-n2nc(CO)c(-c3ccc(C(=O)NS(=O)(=O)c4ccc5ccccc5c4)cc3C(=O)N3CCc4ccccc4C3)c2CCCC)cc1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"9.84";"0.18";"-0.43";"5.80";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031019";"";"None";"731.32";"2";"6.16";"19";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"10.44";"0.20";"1.48";"5.71";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL376254";"";"None";"767.90";"2";"7.94";"10e";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccccc4C(F)(F)F)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"8.49";"0.17";"-1.42";"5.22";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL2031018";"";"None";"866.22";"2";"7.95";"BDBM50384349";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(I)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"50.0";"nM";"7.30";"";"405275";"UO_0000065";"8.43";"0.19";"-0.65";"6.00";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975289";"";"None";"814.41";"2";"6.72";"BDBM232414";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2COCCO)c(C)c1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"405312";"UO_0000065";"9.82";"0.19";"1.28";"5.29";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960836";"";"None";"794.30";"2";"7.89";"BDBM232416";"CCCCN(CCCC(F)(F)F)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"80.0";"nM";"7.10";"";"405314";"UO_0000065";"8.93";"0.18";"-0.79";"5.83";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931099";"";"None";"714.29";"2";"6.29";"BDBM232427";"CCCN(CCC)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"30.0";"nM";"7.52";"";"405325";"UO_0000065";"10.53";"0.21";"1.23";"6.03";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968982";"";"None";"772.68";"2";"8.29";"BDBM232429";"CCCN(CCC)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(F)(F)F)c1Cl";"IC50";"'='";"510.0";"nM";"6.29";"";"405327";"UO_0000065";"8.14";"0.17";"-2.00";"6.02";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2030853";"";"None";"825.39";"2";"9.29";"BDBM50384318";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2cccc(Cl)c2)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"405344";"UO_0000065";"9.33";"0.18";"-1.59";"5.88";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897725";"";"None";"860.82";"2";"6.53";"BDBM232450";"CCCCN(CCCC)C(=O)c1cn(C)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(I)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"405355";"UO_0000065";"9.29";"0.20";"1.47";"5.42";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986556";"";"None";"788.21";"2";"9.04";"BDBM232452";"CCCCN(CCCC)c1ccc(Br)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"60.0";"nM";"7.22";"";"405357";"UO_0000065";"9.16";"0.19";"-1.82";"7.25";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2031008";"";"None";"745.73";"2";"6.87";"BDBM50384339";"CCCN(CCC)c1ncc(Cl)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"405361";"UO_0000065";"10.32";"0.21";"0.83";"5.56";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4206829";"";"None";"892.51";"2";"7.45";"53";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@@H](CC5CC5)CN5CCOCC5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"33.5";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL2159738";"";"None";"864.54";"2";"9.88";"13";"Cc1cc(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"9.21";"0.18";"-1.92";"6.86";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2325773";"";"None";"837.47";"3";"8.75";"19";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5ccnn5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"8.95";"0.18";"-1.26";"5.82";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2326040";"";"None";"907.56";"3";"8.98";"9";"Cc1c(C(N)=O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"8.65";"0.17";"-1.13";"4.94";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4747123";"";"None";"379.42";"0";"3.80";"Entry no. 37-1";"[N-]=[N+]=NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4668636";"Inhibition of FITC-labeled Bak BH3 peptide binding to His6-tagged GST-fused Bcl-xL (unknown origin) expressed in Escherichia coli BL21 preincubated for 10 mins followed by Bak BH3 peptide addition and measured after 30 mins by fluorescence polarization-based competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665682";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"";""
"CHEMBL2312470";"";"None";"461.59";"1";"5.85";"6d";"Nc1ccc(Sc2ccc3c4c(cccc24)C2=NC(=O)C(NCCCc4ccccc4)=C23)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"16.78";"0.31";"1.89";"11.48";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2312469";"";"None";"427.57";"1";"5.80";"6c";"CCCCCCNC1=C2C(=NC1=O)c1cccc3c(Sc4ccc(N)cc4)ccc2c13";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"16.72";"0.31";"1.35";"10.59";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2312484";"";"None";"399.52";"1";"5.02";"6b";"CCCCNC1=C2C(=NC1=O)c1cccc3c(Sc4ccc(N)cc4)ccc2c13";"IC50";"'='";"165.0";"nM";"6.78";"";"";"UO_0000065";"16.98";"0.32";"1.76";"10.05";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2398296";"";"None";"411.87";"1";"5.74";"12e";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"14.01";"0.28";"0.03";"6.58";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2050127";"Inhibition of Bcl-XL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046328";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";"";""
"CHEMBL523927";"KENDOMYCIN";"None";"486.65";"1";"5.13";"1";"CC1=C2O[C@]3(O)C=C2C(=C(O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]3C)[C@H](C)[C@H](O)[C@H]1C";"IC50";"'='";"12300.0";"nM";"4.91";"";"";"UO_0000065";"10.09";"0.19";"-0.22";"5.10";"0";"CHEMBL1002036";"Inhibition of interaction between GST-tagged Bcl-xl and Bak by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143433";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL499851";"";"None";"502.65";"1";"4.03";"2";"CC1=C(O)C(=O)C2=C(C1=O)C(O)C(=O)[C@@H](C)C[C@H](C)C/C(C)=C/[C@@H](C)CC[C@H]1O[C@@H]2[C@H](C)[C@@H](O)[C@H]1C";"IC50";"'='";"230000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1002036";"Inhibition of interaction between GST-tagged Bcl-xl and Bak by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143433";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2398270";"";"None";"376.44";"0";"4.49";"17a";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(N)=O)c2)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1096755";"";"None";"548.60";"2";"5.42";"12c";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3cccc(F)c3)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"9.41";"0.18";"-0.26";"6.09";"0";"CHEMBL1120824";"Displacement of FITC-labeled BH3 peptide from human Bcl-XL after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1097427";"";"None";"552.65";"1";"4.27";"6";"CCOC(=O)COc1cccc(/C=c2\sc3n(c2=O)C(c2ccccc2OC)C2=C(N=3)c3ccccc3CC2)c1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"7.24";"0.14";"-0.27";"5.06";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094809";"";"None";"524.60";"1";"3.79";"8";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4ccc(OCC(=O)O)cc4)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"8.47";"0.16";"0.65";"4.93";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"10.11";"0.20";"0.34";"6.42";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063891";"";"None";"584.77";"1";"4.33";"15";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCNCC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"8.07";"0.16";"0.39";"3.94";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"1, ABT-737";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"10.48";"0.21";"0.64";"6.65";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL3287291";"";"None";"415.43";"0";"3.96";"10";"O=C(O)c1cccc(-c2cn3cccc(C(=O)Nc4nc5ccccc5s4)c3n2)n1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1164031";"";"None";"316.44";"0";"3.48";"8";"CC1=C[C@]23CC[C@@H]4[C@](C)([C@H](O)CC[C@@]4(C)C(=O)O)[C@H]2[C@H]2[C@H](C3)[C@@H]12";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1168411";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by fluorimetric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165962";"1";"Scientific Literature";"J Nat Prod";"2010";"None";"";"";""
"CHEMBL525418";"";"None";"500.68";"2";"5.78";"3";"CO[C@@]12C=C3C(=C(C)C(=O)C(O)=C3[C@@H]3O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]1C)[C@H](C)[C@H](O)[C@H]3C)O2";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1002036";"Inhibition of interaction between GST-tagged Bcl-xl and Bak by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143433";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3923262";"";"None";"944.56";"3";"8.22";"BDBM156388";"CN(CCO)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](N)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"3.0";"nM";"8.52";"";"298866";"UO_0000065";"9.02";"0.18";"0.30";"5.26";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2398279";"";"None";"408.85";"1";"5.02";"24";"C/C(=N\Nc1nc2ccccc2n1C)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398285";"";"None";"377.43";"1";"5.09";"34";"C/C(=N\Nc1nc2ccccc2s1)c1cccc(-c2ccc(C(=O)O)o2)c1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"15.60";"0.30";"0.80";"6.71";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398289";"";"None";"678.76";"2";"5.34";"5";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CSc2ccccc2)CC(=O)N2CCOCC2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"10.05";"0.20";"1.48";"4.61";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398286";"";"None";"388.45";"0";"4.89";"38";"C/C(=N\Nc1nc2ccccc2s1)c1cccc(-c2cccc(C(=O)O)n2)c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"17.64";"0.33";"1.96";"7.84";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398262";"";"None";"415.48";"0";"4.60";"74a";"O=C(O)c1ccnc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"17.12";"0.32";"2.51";"7.09";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398288";"";"None";"389.44";"0";"4.29";"44";"C/C(=N\Nc1nc2ccccc2s1)c1cccc(-c2cncc(C(=O)O)n2)c1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"13.92";"0.26";"1.13";"5.40";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4294620";"";"None";"976.12";"3";"5.93";"34b";"C[C@@H]1CC[C@H]2[C@@H](C)C(OCCN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)C[C@@H]3CO)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4288614";"";"None";"946.09";"3";"6.57";"27d";"C[C@H]1[C@@H](OCCN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"279.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3287287";"";"None";"429.50";"1";"5.12";"6b, enantiomer";"O=C(O)c1cccc(-c2ccc3c(c2)C(C(=O)Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3287300";"";"None";"556.67";"2";"5.89";"21";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCOc3ccccc3)s1)CC2";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"12.69";"0.25";"1.18";"6.75";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3923567";"";"None";"765.34";"2";"7.22";"BDBM232384";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(C#N)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405273";"UO_0000065";"10.06";"0.19";"0.48";"5.29";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981017";"";"None";"896.55";"2";"7.36";"BDBM232391";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OCCCN5CCN(C)CC5)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405282";"UO_0000065";"8.25";"0.16";"0.04";"5.38";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968488";"";"None";"841.48";"2";"7.68";"BDBM232394";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OCCCN(C)C)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405285";"UO_0000065";"9.15";"0.18";"0.02";"5.74";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980078";"";"None";"853.67";"2";"8.76";"BDBM232396";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)ccc(Br)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405287";"UO_0000065";"9.02";"0.19";"-1.06";"6.33";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918855";"";"None";"811.41";"2";"7.05";"BDBM232399";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(C(=O)N(C)C)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"80.0";"nM";"7.10";"";"405290";"UO_0000065";"8.75";"0.17";"0.05";"5.00";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893154";"";"None";"888.32";"2";"9.50";"BDBM232403";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(ccn4Cc4ccc(Cl)c(Cl)c4)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"110.0";"nM";"6.96";"";"405296";"UO_0000065";"7.83";"0.16";"-2.54";"5.50";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912236";"";"None";"844.43";"2";"6.01";"BDBM232404";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4C(=O)N3CCOCC3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"60.0";"nM";"7.22";"";"405297";"UO_0000065";"8.55";"0.17";"1.21";"4.68";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3311485";"";"None";"943.53";"3";"8.76";"10";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC(Oc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"7.86";"0.16";"-1.34";"5.52";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3125476";"";"None";"615.50";"2";"6.08";"X0R";"CCCN(C(=O)N[C@@H](CSCc1ccc(Br)cc1)C(=O)O)C(=O)c1cccc(C#Cc2ccc(F)cc2F)c1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"7.94";"0.17";"-1.19";"5.63";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL1098324";"";"None";"630.72";"2";"5.61";"13";"COc1ccc(C2C3=C(N=c4s/c(=C\c5ccc(OCc6cccc(C(=O)O)c6)c(OC)c5)c(=O)n42)c2ccccc2CC3)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"8.76";"0.16";"-0.09";"5.56";"0";"CHEMBL1120824";"Displacement of FITC-labeled BH3 peptide from human Bcl-XL after 1 hr by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2031031";"";"None";"742.30";"2";"7.14";"37";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2COc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"9.71";"0.19";"0.07";"5.51";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL4216466";"";"None";"945.59";"2";"9.07";"13";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCc3cc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)ccc3C2)C1";"IC50";"'='";"14.6";"nM";"7.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1272224";"";"None";"518.56";"1";"5.00";"6b";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CC(C)C)C2=O)C(=O)c2cc(O)c(O)c(CC(C)C)c2C1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"12.07";"0.22";"1.26";"4.20";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3703620";"";"None";"987.58";"3";"8.03";"BDBM156401";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOC[C@H]2CO)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"363117";"UO_0000065";"8.81";"0.18";"0.67";"5.25";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL133255";"";"None";"262.26";"0";"1.93";"6A7";"COc1c(O)cc2cccc(OC)c(=O)c2c1OC";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL647263";"Inhibitory concentration against Bcl-xl";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144902";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL2398280";"";"None";"405.84";"1";"5.68";"25";"C/C(=N\Nc1ccc2ccccc2n1)c1ccc(-c2cccc(C(=O)O)c2Cl)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398281";"";"None";"348.36";"0";"3.80";"27";"C/C(=N\NC(=O)c1ccccc1)c1ccc(-c2cccc(C(=O)O)c2)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1824805";"";"None";"512.41";"2";"6.36";"10";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1ccc(-c2cc(Cl)cc(Cl)c2)cc1";"IC50";"'='";"4140.0";"nM";"5.38";"";"";"UO_0000065";"10.51";"0.22";"-0.98";"7.43";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1098754";"";"None";"530.61";"2";"5.28";"12a";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3ccccc3)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"12600.0";"nM";"4.90";"";"";"UO_0000065";"9.23";"0.17";"-0.38";"5.78";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3126118";"";"None";"1016.15";"None";"None";"9";"Cc1cc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(S(=O)(=O)C(F)(F)F)c2)ccc1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)nn12";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"8.01";"None";"None";"None";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3126117";"";"None";"553.65";"1";"2.92";"8";"NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"8.28";"0.18";"1.67";"3.86";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3342187";"";"None";"583.74";"2";"6.74";"X0B";"NCc1ccc(OCCCc2sc(-c3ccc4c(c3)/C(=N/Nc3nc5ccccc5s3)CCC4)nc2C(=O)O)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.60";"0.28";"1.78";"6.94";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3984367";"";"None";"798.41";"2";"8.13";"BDBM232387";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OC(C)C)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405277";"UO_0000065";"9.64";"0.19";"-0.43";"5.88";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957469";"";"None";"841.48";"2";"7.68";"BDBM232392";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OC(C)CN(C)C)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"405283";"UO_0000065";"9.51";"0.19";"0.32";"5.96";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1096087";"";"None";"494.57";"0";"4.03";"10";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4ccc(C(=O)O)cc4)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"12600.0";"nM";"4.90";"";"";"UO_0000065";"9.91";"0.19";"0.87";"6.06";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094643";"";"None";"630.72";"2";"5.37";"1f";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4cccc(OCC(=O)O)c4)c(=O)n31)c1ccc(OCc3ccccc3)cc1CC2";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1689139";"";"None";"837.47";"3";"8.51";"HI0";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3cc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc23)cc1[N+](=O)[O-]";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"10.18";"0.20";"0.01";"6.23";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL2063880";"";"None";"525.09";"1";"3.59";"7";"CN1CCN(CCCNC(=O)c2c(-c3ccccc3)c(-c3ccc(Cl)cc3)cn2CC[C@H](O)CO)CC1";"IC50";"'='";"453000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2325761";"";"None";"936.60";"3";"10.45";"29";"CCCn1c(C)c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c1-c1ccc(Cl)cc1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"8.63";"0.17";"-2.36";"5.28";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325772";"";"None";"837.47";"3";"8.75";"18";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5cncn5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"9.25";"0.18";"-1.01";"6.01";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2325771";"";"None";"928.96";"3";"9.92";"17";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(C(=O)O)c(Cl)n(C)c5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"8.96";"0.18";"-1.59";"5.43";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2326041";"";"None";"991.68";"3";"9.52";"10";"Cc1c(C(=O)N[C@H]2C[C@@](C)(O)C2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"7.89";"0.15";"-1.70";"4.73";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3309313";"";"None";"1029.67";"None";"None";"28";"CN(C)CCOc1ccc(-c2ccc(Cl)cc2)c(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)c1";"IC50";"'='";"138.0";"nM";"6.86";"";"";"UO_0000065";"6.66";"None";"None";"None";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3287295";"";"None";"548.67";"2";"6.38";"16";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(CCCc3ccccc3)c(C(=O)O)n1)CC2";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"13.66";"0.26";"1.11";"7.85";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3400497";"";"None";"552.73";"2";"7.84";"X8U";"O=C(O)c1nc(-c2ccc3c(c2)/C(=N/Nc2nc4ccccc4s2)CCC3)sc1CCCCc1ccccc1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"15.96";"0.31";"0.98";"10.09";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3400495";"";"None";"908.55";"3";"9.58";"03B";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(NC(CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"9.05";"0.18";"-1.36";"5.36";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3309313";"";"None";"1029.67";"None";"None";"28";"CN(C)CCOc1ccc(-c2ccc(Cl)cc2)c(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"7.77";"None";"None";"None";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1094250";"1,1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMETHYL-N5-((R)-2-PHENYLPROPYL)-N5'-((R)-2-PHENYLPROPYL)-2,2'-BINAPHTHYL-5,5'-DICARBOXAMIDE (ATROPISOMERIC MIX)";"None";"700.79";"3";"7.58";"(R, +, R)-12";"Cc1cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"9.29";"0.17";"-1.07";"3.62";"0";"CHEMBL1106536";"Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157826";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"3";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.56";"0.21";"0.10";"4.92";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1689141";"";"None";"924.54";"3";"8.89";"29";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3cc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)ccc23)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"8.89";"0.18";"-0.67";"6.43";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1689144";"";"None";"911.59";"3";"9.07";"32";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc4c(NS(=O)(=O)c5ccc(N[C@H](CCN6CCOCC6)CSc6ccccc6)c([N+](=O)[O-])c5)ncnc4c3)CC2)C1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"8.45";"0.17";"-1.37";"5.27";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1689146";"";"None";"998.66";"3";"9.46";"34";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc4c(NS(=O)(=O)c5ccc(N[C@H](CCN6CCOCC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)ncnc4c3)CC2)C1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"7.55";"0.15";"-1.92";"5.50";"0";"CHEMBL1693053";"Displacement of biotinylated Bim-BH3 from GST-tagged Bcl-Xl by AlphaScreen competitive assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1687940";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2030849";"";"None";"832.98";"2";"9.32";"3f";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1cccc(Oc2ccccc2)c1";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"7.60";"0.14";"-2.99";"4.62";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030851";"";"None";"790.94";"2";"8.64";"3h";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"9.43";"0.18";"-1.18";"5.70";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL51483";"GOSSYPOL";"3.0";"518.56";"3";"6.38";"(+)-1";"Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"12.09";"0.23";"-0.11";"4.03";"0";"CHEMBL1106536";"Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157826";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094366";"(S)-1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMETHYL-N5-((S)-2-PHENYLPROPYL)-N5'-((S)-2-PHENYLPROPYL)-2,2'-BINAPHTHYL-5,5'-DICARBOXAMIDE (ATROPISOMERIC MIX)";"None";"700.79";"3";"7.58";"(S, +, S)-14";"Cc1cc2c(C(=O)NC[C@@H](C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC[C@@H](C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"9.07";"0.17";"-1.22";"3.54";"0";"CHEMBL1106536";"Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157826";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2030846";"";"None";"712.83";"2";"7.05";"3c";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)O)nn1-c1ccccc1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"10.55";"0.20";"0.47";"5.43";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031016";"";"None";"890.46";"2";"8.62";"16";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(OCc5ccc(C(=O)O)cc5)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"8.73";"0.17";"-0.85";"4.62";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031021";"";"None";"759.37";"2";"6.58";"21";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4CC)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"10.23";"0.20";"1.19";"6.22";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031022";"";"None";"890.33";"2";"9.06";"22";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4Cc3ccc(Cl)c(Cl)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"8.26";"0.17";"-1.70";"5.89";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031028";"";"None";"852.50";"2";"6.96";"31";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN2CCN(C)CC2)c(C)c1Cl";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"8.98";"0.17";"0.70";"5.98";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3400496";"";"None";"586.74";"2";"7.00";"H1I";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(S(=O)(=O)NC(=O)CCCCCc3ccccc3)c2)o1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"10.74";"0.21";"-0.70";"5.54";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3287282";"";"None";"414.49";"1";"5.21";"H0Y";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N/Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"18.52";"0.35";"2.47";"8.78";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL222069";"";"None";"767.90";"2";"7.94";"10f";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4ccc(C(F)(F)F)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"7.67";"0.15";"-2.05";"4.71";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL551288";"APOGOSSYPOL";"None";"462.54";"2";"6.76";"2, Apogossypol";"Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"11.74";"0.22";"-1.33";"4.48";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2312476";"";"None";"472.59";"1";"7.03";"8d";"CC(C)c1ccc(Oc2ccc3c4c(cccc24)C2=NC(=O)C(NCCCc4ccccc4)=C23)cc1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"15.73";"0.28";"0.40";"14.66";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2312473";"";"None";"478.57";"1";"6.12";"7d";"O=C1N=C2C(=C1NCCCc1ccccc1)c1ccc(Sc3ccc(OO)cc3)c3cccc2c13";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"15.20";"0.28";"1.16";"10.26";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2312471";"";"None";"414.53";"1";"5.44";"7b";"CCCCNC1=C2C(=NC1=O)c1cccc3c(Sc4ccc(OC)cc4)ccc2c13";"IC50";"'='";"315.0";"nM";"6.50";"";"";"UO_0000065";"15.68";"0.30";"1.06";"12.83";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL1672082";"";"None";"353.41";"0";"4.19";"6a";"N#CC1=C2C(=NC1=O)c1cccc3c(Sc4ccc(N)cc4)ccc2c13";"IC50";"'='";"291.0";"nM";"6.54";"";"";"UO_0000065";"18.49";"0.34";"2.35";"8.25";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL1095312";"";"None";"606.65";"2";"6.72";"12k";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3cccc(F)c3)C3=C(N=4)/C(=C/c4cccc(F)c4)CCC3)o2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094443";"";"None";"554.62";"1";"3.94";"1e";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4cccc(OCC(=O)O)c4)c(=O)n31)c1ccccc1C(OC)C2";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL481409";"";"None";"290.36";"0";"4.28";"12";"Oc1cc(Cc2ccccc2)c(Cc2ccccc2)cc1O";"IC50";"'='";"8500.0";"nM";"5.07";"";"";"UO_0000065";"17.46";"0.31";"0.79";"12.53";"0";"CHEMBL1107439";"Displacement of FITC-conjugated BH3-Bak peptide from human recombinant Bcl-XL expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157820";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2398290";"";"None";"377.43";"1";"5.01";"6";"Cc1c(C(=O)O)cccc1-c1ccc(/C=N/Nc2nc3ccccc3s2)o1";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"13.69";"0.26";"0.16";"5.89";"0";"CHEMBL2399242";"Displacement of biotinylated-Bak from Bcl-Xl (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398272";"";"None";"429.86";"1";"5.88";"22a";"C/C(=N\Nc1nc2ccc(F)cc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"12.56";"0.25";"-0.48";"6.15";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398283";"";"None";"424.91";"1";"5.49";"30b";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)n1C";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"14.02";"0.28";"0.47";"7.49";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398249";"";"None";"443.53";"1";"5.10";"63a";"CCN1CC/C(=N/Nc2nc3ccccc3s2)c2cc(-c3cccc(C(=O)O)n3)ccc21";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"16.48";"0.31";"2.21";"8.06";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398260";"";"None";"420.52";"1";"5.27";"71a";"O=C(O)c1csc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)n1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"18.12";"0.36";"2.35";"8.71";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2159736";"";"None";"921.59";"3";"9.24";"11";"CNC(=O)c1c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n(C)c1C";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"8.92";"0.18";"-1.02";"5.67";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1824824";"";"None";"478.40";"1";"5.96";"27";"CCCCOc1ccc(S(=O)(=O)NC(=O)c2cccc(-c3ccc(Cl)c(Cl)c3)c2)cc1";"IC50";"'='";"12110.0";"nM";"4.92";"";"";"UO_0000065";"10.28";"0.22";"-1.04";"6.78";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL410802";"";"None";"2437.73";"None";"None";"Bid BH3 peptide";"CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"2.95";"None";"None";"None";"0";"CHEMBL909446";"Displacement of FAM-Bak from human Bcl-xL by FP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137390";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1272170";"";"None";"490.51";"0";"4.85";"6a";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(O)c(O)c(C(C)C)c2C1=O";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"12.64";"0.24";"1.35";"4.16";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL332055";"";"None";"320.26";"1";"5.38";"71";"CN(C)CCC=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1";"IC50";"'='";"180000.0";"nM";"3.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL643724";"Inhibitory concentration against B-Cell Lymphoma xL (Bcl-xL) Bak-peptide binding region";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148343";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1095310";"";"None";"560.63";"2";"5.29";"12i";"COc1cccc(C2C3=C(N=c4s/c(=C\c5ccc(-c6cccc(C(=O)O)c6)o5)c(=O)n42)c2ccccc2CC3)c1";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"9.16";"0.17";"-0.15";"5.46";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1094645";"";"None";"570.62";"2";"5.22";"1h";"O=C(O)COc1cccc(/C=c2\sc3n(c2=O)C(c2cccc(F)c2)C2=C(N=3)/C(=C/c3cccc(F)c3)CCC2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269077";"";"None";"642.70";"2";"6.95";"6g";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCCc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(CCCc3ccccc3)c2C1=O";"IC50";"'='";"1440.0";"nM";"5.84";"";"";"UO_0000065";"9.09";"0.17";"-1.11";"3.92";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2326039";"";"None";"958.59";"3";"7.44";"23";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(C(=O)NS(C)(=O)=O)ncn5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"8.43";"0.17";"0.64";"4.21";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2326037";"";"None";"851.50";"3";"8.97";"21";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5cn(C)nc5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"8.91";"0.18";"-1.38";"5.89";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2159739";"";"None";"922.57";"3";"10.06";"5, BM-956";"CCn1c(C)c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c1-c1ccc(Cl)cc1";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"8.87";"0.17";"-1.88";"5.34";"1";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1374578";"";"None";"413.84";"1";"5.33";"5, BI21-C6";"O=C(O)c1ccccc1C(=O)c1ccc(Sc2ccc(Cl)cc2)c([N+](=O)[O-])c1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"15.23";"0.31";"0.97";"6.46";"0";"CHEMBL1072273";"Displacement of biotinylated-BH3 peptide from Bcl-xL by TR-FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157656";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3953270";"";"None";"987.59";"3";"8.03";"BDBM156400";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCO[C@@H](CO)C2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"298878";"UO_0000065";"9.11";"0.19";"0.97";"5.44";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2031024";"";"None";"770.35";"2";"6.71";"27";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"10.28";"0.20";"1.21";"5.58";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031026";"";"None";"841.48";"2";"7.29";"29";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2COCCN(C)C)c(C)c1Cl";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"8.71";"0.17";"0.04";"5.46";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2159741";"";"None";"934.58";"3";"10.38";"16";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C1CC1";"IC50";"'='";"7.7";"nM";"8.11";"";"";"UO_0000065";"8.68";"0.17";"-2.27";"5.29";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3311484";"";"None";"975.51";"3";"9.10";"9";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCP(=O)(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"7.94";"0.17";"-1.36";"5.45";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3309311";"";"None";"1043.65";"None";"None";"25";"CN(C)C(=O)COc1cccc(-c2ccc(Cl)cc2)c1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"7.67";"None";"None";"None";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311489";"";"None";"975.60";"3";"8.49";"14";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([S@+]([O-])c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"7.45";"0.16";"-1.22";"4.90";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2063890";"";"None";"500.65";"1";"4.92";"14";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-]";"IC50";"'='";"547000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063892";"";"None";"1033.77";"None";"None";"16";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(C)c5C(=O)NCCCN5CCN(C)CC5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"4.9";"nM";"8.31";"";"";"UO_0000065";"8.04";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1095308";"";"None";"580.67";"2";"6.43";"12f";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3cccc5ccccc35)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"13400.0";"nM";"4.87";"";"";"UO_0000065";"8.39";"0.15";"-1.56";"5.75";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"2; ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3287296";"";"None";"564.67";"2";"6.22";"17";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1ccc(CCCOc3ccccc3)c(C(=O)O)n1)CC2";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.81";"0.26";"1.58";"7.45";"0";"CHEMBL3291801";"Displacement of 26-mer BIMBH3 peptide from GST-tagged Bcl-Xl (unknown origin) by AlphaScreen assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3286340";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1269077";"";"None";"642.70";"2";"6.95";"BDBM142755";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCCc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(CCCc3ccccc3)c2C1=O";"IC50";"'='";"1440.0";"nM";"5.84";"";"278896";"UO_0000065";"9.09";"0.17";"-1.11";"3.92";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2398291";"";"None";"363.40";"0";"4.70";"11";"O=C(O)c1cccc(-c2ccc(/C=N/Nc3nc4ccccc4s3)o2)c1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"13.76";"0.26";"0.30";"5.70";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398290";"";"None";"377.43";"1";"5.01";"6";"Cc1c(C(=O)O)cccc1-c1ccc(/C=N/Nc2nc3ccccc3s2)o1";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"13.55";"0.26";"0.10";"5.83";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398282";"";"None";"427.94";"1";"6.21";"30a";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)s1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"13.54";"0.28";"-0.41";"7.77";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398284";"";"None";"410.89";"1";"5.48";"30c";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)[nH]1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.17";"0.28";"0.34";"6.44";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1824804";"";"None";"477.97";"1";"5.70";"9";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1ccc(-c2ccc(Cl)cc2)cc1";"IC50";"'='";"3790.0";"nM";"5.42";"";"";"UO_0000065";"11.34";"0.22";"-0.28";"7.48";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824807";"";"None";"447.49";"1";"5.40";"12";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'='";"33520.0";"nM";"4.47";"";"";"UO_0000065";"10.00";"0.19";"-0.93";"6.17";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2063894";"";"None";"850.51";"2";"9.57";"18";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5cn(C)cc5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"34.4";"nM";"7.46";"";"";"UO_0000065";"8.78";"0.17";"-2.11";"6.43";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063897";"";"None";"922.57";"3";"9.83";"21";"CCc1c(-c2ccc(Cl)cc2)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(C(=O)O)n1C";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"8.81";"0.17";"-1.71";"5.30";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3703621";"";"None";"987.58";"3";"8.03";"BDBM156402";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOC[C@@H]2CO)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"363118";"UO_0000065";"8.81";"0.18";"0.67";"5.25";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703625";"";"None";"1051.57";"None";"None";"BDBM156407";"COP(=O)(O)O[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"363122";"UO_0000065";"8.56";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"3; ABT-199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"IC50";"'='";"52.7";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL501427";"";"None";"542.71";"2";"5.42";"4";"CC1=C2O[C@]34OC(C)(C)O[C@@H]3C2=C(C(=O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]4C)[C@H](C)[C@H](O)[C@H]1C";"IC50";"'='";"9500.0";"nM";"5.02";"";"";"UO_0000065";"9.25";"0.18";"-0.40";"5.50";"0";"CHEMBL1002036";"Inhibition of interaction between GST-tagged Bcl-xl and Bak by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143433";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL509351";"";"None";"582.78";"2";"6.34";"6";"CC1=C2O[C@]34OC5(CCCCC5)O[C@@H]3C2=C(C(=O)C1=O)[C@@H]1O[C@H](CC[C@H](C)/C=C(\C)C[C@@H](C)C[C@@H]4C)[C@H](C)[C@H](O)[C@H]1C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1002036";"Inhibition of interaction between GST-tagged Bcl-xl and Bak by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143433";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3924533";"";"None";"984.63";"3";"9.23";"BDBM156413";"CN(C)[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"298888";"UO_0000065";"7.87";"0.16";"-1.49";"6.03";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2398266";"";"None";"422.42";"0";"5.00";"12i";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc([N+](=O)[O-])c(C(=O)O)c2)o1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"13.60";"0.26";"0.74";"4.39";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398293";"";"None";"377.43";"1";"5.09";"12b";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc(C(=O)O)cc2)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398286";"";"None";"388.45";"0";"4.89";"38";"C/C(=N\Nc1nc2ccccc2s1)c1cccc(-c2cccc(C(=O)O)n2)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"17.82";"0.34";"2.03";"7.91";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4286682";"";"None";"916.02";"3";"5.87";"27h";"C[C@@H]1CC[C@@H]2[C@]34OO[C@](C)(CC[C@@H]13)O[C@H]4O[C@]2(C)C(=O)N1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c([N+](=O)[O-])c3)c(Oc3cnc4[nH]ccc4c3)c2)CC1";"IC50";"'='";"512.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL330959";"";"None";"611.70";"2";"9.94";"72";"CN(C)CC/C=C(\c1ccc(Cl)cc1)c1ccc(CCCc2ccc(/C(=C\CCN(C)C)c3ccc(Cl)cc3)cc2)cc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL643724";"Inhibitory concentration against B-Cell Lymphoma xL (Bcl-xL) Bak-peptide binding region";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148343";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1097428";"";"None";"524.60";"1";"3.79";"7";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4ccccc4OCC(=O)O)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"12100.0";"nM";"4.92";"";"";"UO_0000065";"9.37";"0.18";"1.13";"5.46";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL552735";"";"None";"586.68";"3";"8.08";"12e";"Cc1cc2c(CCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(CCc3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"9.30";"0.17";"-2.62";"4.49";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2063883";"";"None";"1107.84";"None";"None";"7, BM-907";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(-c6ccc(Cl)cc6)cn(CC[C@H](O)CO)c5C(=O)NCCCN5CCN(C)CC5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"6.2";"nM";"8.21";"";"";"UO_0000065";"7.41";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL541496";"";"None";"728.84";"3";"7.58";"8q";"CCc1ccc(CCNC(=O)c2c(O)c(O)cc3c(O)c(-c4c(C)cc5c(C(=O)NCCc6ccc(CC)cc6)c(O)c(O)cc5c4O)c(C)cc23)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"9.50";"0.18";"-0.66";"3.85";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL552287";"";"None";"672.73";"3";"6.46";"8n";"Cc1cc2c(C(=O)NCCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCCc3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"9.06";"0.17";"-0.36";"3.40";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2159744";"";"None";"2681.08";"None";"None";"NOXA";"CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"1.85";"None";"None";"None";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2159737";"";"None";"908.55";"3";"9.58";"12";"Cc1c(C(=O)O)c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)n1C";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"9.05";"0.18";"-1.36";"5.36";"0";"CHEMBL2162633";"Inhibition of human N-terminal His8-tagged Bcl-XL expressed in Escherichia coli BL21(DE3) assessed as inhibition of Fluorescein-labeled BAK binding after 1 to 2 hrs by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2157965";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1824822";"";"None";"489.55";"1";"5.28";"25";"COc1ccc(-c2cccc(C(=O)NS(=O)(=O)c3ccc(Oc4ccccc4)cc3)c2)cc1OC";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824827";"";"None";"528.41";"2";"6.58";"30";"COc1ccccc1Oc1ccc(S(=O)(=O)NC(=O)c2cccc(-c3ccc(Cl)c(Cl)c3)c2)cc1";"IC50";"'='";"3760.0";"nM";"5.42";"";"";"UO_0000065";"10.27";"0.21";"-1.16";"6.64";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2398171";"";"None";"383.45";"1";"5.15";"51";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2ccc(C(=O)O)o2)s1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"15.05";"0.30";"0.62";"6.58";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398258";"";"None";"448.53";"0";"4.38";"67a";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CC[S+]3[O-])n1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"16.26";"0.32";"2.91";"6.60";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3309310";"";"None";"946.54";"3";"6.77";"24";"Cn1ncc(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)c1-c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"8.45";"0.17";"1.23";"5.47";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1269107";"";"None";"586.60";"2";"5.78";"BDBM142756";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccccc3)c2C1=O";"IC50";"'='";"340.0";"nM";"6.47";"";"278892";"UO_0000065";"11.03";"0.20";"0.69";"4.34";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3930883";"";"None";"999.64";"3";"7.91";"BDBM156390";"N[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCN(CCO)CC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"298868";"UO_0000065";"7.83";"0.16";"-0.09";"4.73";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2398297";"";"None";"411.87";"1";"5.74";"12f";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(=O)O)c2Cl)o1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"13.52";"0.27";"-0.17";"6.35";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1449836";"";"None";"335.39";"0";"4.68";"SID4260465";"c1ccc(CSc2nnc(-c3ccco3)c(-c3ccco3)n2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1446458";"";"None";"367.37";"0";"1.82";"SID57263246";"CCC(=O)Nc1ccc(C(=O)COC(=O)c2nc3nccc(C)n3n2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3197557";"";"None";"311.30";"0";"1.70";"SID49676808";"Cc1nc2ccccc2c(=O)n1/N=C/c1ccc(O)c(O)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2322020";"";"None";"960.54";"3";"8.22";"20";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ncnc3c2CCN(C2CCN(Cc4cc(F)ccc4-c4ccc(Cl)cc4)CC2)C3=O)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"7.97";"0.16";"-0.56";"5.28";"0";"CHEMBL2328209";"Inhibition of Bcl-xL/BAK (unknown origin) interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321763";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1672077";"";"None";"368.42";"0";"4.62";"7a";"COc1ccc(Sc2ccc3c4c(cccc24)C2=NC(=O)C(C#N)=C23)cc1";"IC50";"'='";"833.0";"nM";"6.08";"";"";"UO_0000065";"16.50";"0.31";"1.46";"9.73";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL2312482";"";"None";"405.57";"0";"4.62";"5e";"CCCCCCNC1=C2C(=NC1=O)c1cccc3c(N4CCSCC4)ccc2c13";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"17.43";"0.33";"2.45";"15.82";"0";"CHEMBL2318339";"Binding affinity to N-terminal 8xHis tagged cBcl-XL (unknown origin) expressed in Escherichia coli BL21 (DE3) by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2311285";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL539481";"";"None";"741.62";"3";"8.80";"8k";"Cc1cc2c(C(=O)NC(C)c3ccc(Cl)cc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC(C)c3ccc(Cl)cc3)c(O)c(O)cc2c1O";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"9.38";"0.18";"-1.84";"3.87";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2398251";"";"None";"428.52";"1";"5.46";"63c";"CC1CCc2ccc(-c3cccc(C(=O)O)n3)cc2/C1=N\Nc1nc2ccccc2s1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"15.37";"0.29";"1.13";"7.53";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398250";"";"None";"428.52";"1";"5.60";"63b";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCCC3)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.67";"0.35";"2.40";"9.15";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398269";"";"None";"377.43";"0";"4.79";"16b";"COC(=O)c1cccc(-c2ccc(/C=N/Nc3nc4ccccc4s3)o2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"4";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"10.26";"0.20";"-0.06";"4.78";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4206007";"";"None";"801.30";"2";"6.99";"39";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N5CC(F)(F)C5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1418601";"";"None";"392.39";"0";"3.38";"SID17510694";"CC(=O)OCCCNc1cc(SCc2ccco2)c2nonc2c1[N+](=O)[O-]";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL571296";"";"None";"337.43";"0";"1.19";"SID3711664";"Cn1cnnc1SCC(=O)Nc1sc2c(c1C(N)=O)CCC2";"IC50";"'>'";"36268.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2007178";"";"None";"452.26";"0";"4.45";"SID26725822";"O=C(O)c1ccc(-n2cccc2/C=N\NC(=O)c2cc3cc(Br)ccc3o2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1824821";"";"None";"498.39";"1";"6.57";"23";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1cccc(-c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"1970.0";"nM";"5.71";"";"";"UO_0000065";"11.45";"0.24";"-0.86";"7.87";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL2398263";"";"None";"414.49";"1";"5.21";"74b";"O=C(O)c1cc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)ccn1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"17.42";"0.33";"2.01";"8.26";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398275";"";"None";"479.87";"1";"6.76";"22d";"C/C(=N\Nc1nc2ccc(C(F)(F)F)cc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL538616";"";"None";"700.79";"3";"7.58";"8r";"Cc1cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"9.93";"0.18";"-0.62";"3.87";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3311488";"";"None";"975.60";"3";"8.49";"13";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([S@@+]([O-])c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1720.0";"nM";"5.76";"";"";"UO_0000065";"5.91";"0.12";"-2.73";"3.89";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311488";"";"None";"975.60";"3";"8.49";"13";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([S@@+]([O-])c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"8.16";"0.17";"-0.53";"5.37";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311491";"";"None";"970.60";"3";"8.50";"17";"NCC1(Cc2ccccc2-c2ccc(Cl)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3309309";"";"None";"932.51";"3";"6.76";"23";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3cn[nH]c3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"7.96";"0.16";"0.66";"4.73";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3984880";"";"None";"1039.55";"None";"None";"BDBM156385";"CCN(CCOP(=O)(O)O)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"298863";"UO_0000065";"8.66";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL221295";"";"None";"808.04";"2";"8.13";"8n";"COC1(Cc2ccc(-c3ccccc3)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"8.41";"0.16";"-1.33";"5.07";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL375770";"";"None";"745.97";"2";"6.77";"8j";"COC1(Cc2ccccc2C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"9.58";"0.19";"0.38";"5.33";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3958535";"";"None";"1093.65";"None";"None";"BDBM156406";"CCOP(=O)(OCC)O[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"298883";"UO_0000065";"7.24";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2326747";"";"None";"942.60";"3";"9.00";"19";"CC(c1ccccc1-c1ccc(Cl)cc1)N1CCC(N2CCc3c(ncnc3NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)C2)CC1";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"7.36";"0.15";"-2.06";"5.43";"0";"CHEMBL2328209";"Inhibition of Bcl-xL/BAK (unknown origin) interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321763";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1824801";"";"None";"443.52";"1";"5.05";"7b";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1cccc(-c2ccccc2)c1";"IC50";"'='";"15080.0";"nM";"4.82";"";"";"UO_0000065";"10.87";"0.21";"-0.23";"6.65";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824802";"";"None";"443.52";"1";"5.05";"7c";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1ccccc1-c1ccccc1";"IC50";"'='";"42720.0";"nM";"4.37";"";"";"UO_0000065";"9.85";"0.19";"-0.68";"6.03";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824810";"";"None";"429.50";"1";"5.26";"14";"O=C(NS(=O)(=O)c1ccc(-c2ccccc2)cc1)c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"161300.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL4551344";"A-1210227";"None";"904.37";"3";"8.88";"EUB0000746";"O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1";"IC50";"'>'";"25000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4883618";"Time-resolved fluorescence energy transfer (TR-FRET) with BCL2L1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Assay publication: PMID: 25313317 | Target protein length: full length | Target protein type: recombinant protein (GST-Bcl-xL)";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Num of experiments None 3.0 None";"";""
"CHEMBL4851700";"";"None";"902.01";"3";"8.52";"24m";"CN1CCC(COc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(C(F)(F)F)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])C1";"IC50";"'='";"16.8";"nM";"7.78";"";"";"UO_0000065";"8.62";"0.17";"-0.75";"4.76";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL1520254";"";"None";"487.33";"0";"4.43";"SID46500141";"COc1ccc(C2=CC3=C(Br)C(=O)C(C)(OC(=O)c4cccs4)C(=O)C3=CO2)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1415426";"";"None";"315.42";"0";"3.37";"SID14726494";"O=C(Cc1cccs1)Nc1nnc(Cc2ccccc2)s1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL218524";"";"None";"813.45";"2";"7.88";"23n";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccccc4Cl)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'<'";"60.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4279468";"";"None";"944.08";"3";"5.55";"29b";"C[C@H]1[C@@H](CC(=O)N2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@]3(C)O[C@]24[C@H]1CC[C@@H](C)[C@@H]4C[C@H]3O";"IC50";"'='";"765.0";"nM";"6.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4280705";"";"None";"962.09";"3";"5.68";"27e";"C[C@@H]1CC[C@H]2[C@@](C)(O)[C@@H](OCCN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'='";"287.0";"nM";"6.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL371861";"";"None";"551.62";"2";"5.72";"1";"O=C(NS(=O)(=O)c1ccc(NCCSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL858939";"Inhibitory activity against Bcl-XL in presence of 1% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149415";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"Navitoclax, ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"7.41";"0.15";"-1.61";"5.63";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3309262";"";"None";"1043.65";"None";"None";"26";"CN(C)C(=O)COc1ccc(-c2ccc(Cl)cc2)c(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"7.67";"None";"None";"None";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311331";"";"None";"982.61";"3";"8.64";"3";"O=S(=O)(NC(=C1COC1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311490";"";"None";"966.57";"3";"9.07";"16";"N#CC1(Cc2ccccc2-c2ccc(Cl)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1512376";"";"None";"361.45";"0";"3.80";"SID56319582";"Cc1ccc(C)c(NC(=O)CN(C)C(=O)c2cccc(-n3cccc3)c2)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1991426";"";"None";"414.87";"0";"3.30";"SID24779881";"O=C(N/N=C/c1ccncc1)c1cccc(S(=O)(=O)Nc2ccc(Cl)cc2)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4211198";"";"None";"900.43";"2";"6.92";"55";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5(CN6CC(F)(F)C6)COC5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1373095";"";"None";"460.52";"0";"4.22";"SID26658134";"O=C(Nc1cccc(S(=O)(=O)NC2=NCCC2)c1)c1cc(-c2ccco2)nc2ccccc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1699206";"";"None";"513.54";"1";"4.16";"SID17385775";"O=C(N/N=C/c1ccc(-c2ccc(S(=O)(=O)Nc3ncccn3)cc2)o1)c1cc2ccccc2cc1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3903272";"";"None";"959.58";"3";"8.65";"BDBM156380";"CCN(CCO)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"0.8";"nM";"9.10";"";"298859";"UO_0000065";"9.48";"0.19";"0.45";"5.82";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2070024";"";"None";"612.81";"2";"8.49";"42; BH3-M6";"CC(C)Cc1cc(-c2ccc(-c3ccc(CCC(=O)O)cc3CC(C)C)cc2Cc2ccccc2)ccc1OCC(=O)O.N.N";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.06";"0.18";"-2.67";"6.95";"0";"CHEMBL4052863";"Inhibition of Bak BH3 peptide binding to GST-tagged human Bcl-xL after 3 hrs by Western blotting-based GST pull-down assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL268908";"";"None";"761.97";"3";"6.47";"8k";"COc1ccccc1CC1(OC)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"9.35";"0.18";"0.65";"4.97";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL1423852";"";"None";"291.31";"0";"3.45";"SID24829573";"O=C(/C=C/c1ccco1)N(c1ccccn1)c1ccccn1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1503852";"";"None";"404.43";"0";"2.52";"SID49822459";"O=C(CN1C(=O)/C(=C/c2ccco2)SC1=S)Nc1ccc(O)c(C(=O)O)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1543965";"";"None";"314.33";"0";"2.31";"SID17401638";"Oc1ccc(C2=Nn3c(nnc3-c3ccco3)SC2)cc1O";"IC50";"'='";"68732.0";"nM";"4.16";"";"Not Active";"UO_0000065";"13.24";"0.26";"1.85";"4.31";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1490685";"";"None";"414.49";"0";"3.92";"SID56423669";"N#Cc1c(SCC(=O)Nc2nc3ccccc3s2)sc2c(O)cc(O)nc12";"IC50";"'='";"63255.0";"nM";"4.20";"";"Not Active";"UO_0000065";"10.13";"0.21";"0.28";"3.52";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3960038";"";"None";"939.75";"2";"11.38";"BDBM232439";"CCCCN(C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)ccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl)c1cccc(-c2ccc(Cl)cc2)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"405337";"UO_0000065";"7.87";"0.16";"-3.98";"6.08";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4863897";"";"None";"936.45";"3";"9.68";"17a";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2C(F)(F)F)C1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"";""
"CHEMBL374941";"";"None";"700.89";"2";"6.32";"10j";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(=Cc4cccnc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"7.92";"0.15";"-0.77";"4.03";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL4446378";"TAPOTOCLAX";"1.0";"613.22";"2";"5.90";"2; AMG 176";"CO[C@H]1/C=C/C[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c2ccc3c(c2)N(C[C@@H]2CC[C@H]21)C[C@@]1(CCCc2cc(Cl)ccc21)CO3";"IC50";"'='";"1420.0";"nM";"5.85";"";"";"UO_0000065";"9.54";"0.19";"-0.05";"6.88";"0";"CHEMBL4356646";"Inhibition of recombinant C-terminal His6x-tagged human Bcl-xL (1 to 196 residues) expressed in Escherichia coli cells interaction with biotinylated human Bim (51 to 76 residues) incubated for 60 mins by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354823";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1094366";"(S)-1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMETHYL-N5-((S)-2-PHENYLPROPYL)-N5'-((S)-2-PHENYLPROPYL)-2,2'-BINAPHTHYL-5,5'-DICARBOXAMIDE (ATROPISOMERIC MIX)";"None";"700.79";"3";"7.58";"(S, +, S)-14";"Cc1cc2c(C(=O)NC[C@@H](C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC[C@@H](C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"8.83";"0.16";"-1.39";"3.45";"0";"CHEMBL1106536";"Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157826";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269070";"";"None";"728.75";"3";"5.67";"8a";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(=O)NCC(C)c3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(C(=O)NCC(C)c3ccccc3)c2C1=O";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"8.91";"0.16";"0.82";"3.13";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269074";"";"None";"626.75";"2";"7.63";"6d";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCC3CCCCC3)C2=O)C(=O)c2cc(O)c(O)c(CCC3CCCCC3)c2C1=O";"IC50";"'='";"12650.0";"nM";"4.90";"";"";"UO_0000065";"7.81";"0.15";"-2.73";"3.28";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1269107";"";"None";"586.60";"2";"5.78";"6i";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccccc3)c2C1=O";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"11.03";"0.20";"0.69";"4.34";"0";"CHEMBL1273516";"Displacement of F-BakBH3 from Bcl-xL after 30 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1269007";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL552287";"";"None";"672.73";"3";"6.46";"8n";"Cc1cc2c(C(=O)NCCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCCc3ccccc3)c(O)c(O)cc2c1O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1031062";"Binding affinity to Bcl-xL by isothermal titration calorimetry assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL541427";"";"None";"696.76";"3";"6.30";"8s";"Cc1cc2c(C(=O)NC3Cc4ccccc4C3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC3Cc4ccccc4C3)c(O)c(O)cc2c1O";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"8.71";"0.16";"-0.23";"3.38";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL541004";"";"None";"656.78";"3";"7.13";"8m";"Cc1cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC3CCCCC3)c(O)c(O)cc2c1O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"9.07";"0.17";"-1.17";"3.32";"0";"CHEMBL1031850";"Displacement of F-BakBH3 from Bcl-xL by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158469";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3954188";"";"None";"791.80";"2";"7.82";"BDBM232406";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)c(Cl)cn4CC)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405299";"UO_0000065";"9.34";"0.19";"-0.42";"5.84";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906577";"";"None";"907.70";"2";"9.07";"BDBM232424";"CCCCN(Cc1ccc(Cl)c(Cl)c1)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"50.0";"nM";"7.30";"";"405322";"UO_0000065";"8.04";"0.17";"-1.77";"5.14";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964186";"";"None";"712.32";"2";"7.71";"BDBM232426";"CCCCN(CCCC)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"690.0";"nM";"6.16";"";"405324";"UO_0000065";"8.65";"0.17";"-1.55";"5.89";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2107358";"OBATOCLAX MESYLATE";"3.0";"413.50";"0";"4.49";"7, obatoclax";"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O";"IC50";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"16.79";"0.30";"0.84";"10.02";"0";"CHEMBL1072274";"Inhibition of Bcl-xL expressed in Saccharomyces cerevisiae";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157656";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1095146";"";"None";"512.56";"1";"3.92";"1b";"O=C(O)COc1cccc(/C=c2\sc3n(c2=O)C(c2cccc(F)c2)C2=C(N=3)c3ccccc3CC2)c1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"10.28";"0.19";"1.35";"6.51";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3703624";"";"None";"1093.65";"None";"None";"BDBM156406";"CCOP(=O)(OCC)O[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"363121";"UO_0000065";"7.24";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1165054";"";"None";"318.46";"0";"4.01";"5";"C[C@]12CCC[C@@](C)(C(=O)O)[C@@H]1CC[C@]13C[C@@H](C=C[C@@H]12)[C@@](C)(O)C3";"IC50";"'='";"380000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1168411";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by fluorimetric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165962";"1";"Scientific Literature";"J Nat Prod";"2010";"None";"";"";""
"CHEMBL1164319";"";"None";"318.46";"0";"3.70";"4";"C[C@]12C[C@]34CC[C@@H]5[C@](C)([C@H](O)CC[C@@]5(C)C(=O)O)[C@@H]3C[C@H]1[C@H]2C4";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1168411";"Displacement of fluorescently-tagged BH3 peptide from Bcl-XL by fluorimetric assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1165962";"1";"Scientific Literature";"J Nat Prod";"2010";"None";"";"";""
"CHEMBL4210809";"";"None";"753.31";"2";"6.60";"38";"CN(C)c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCC(C)(C)C4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"218.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4209621";"";"None";"783.34";"2";"5.97";"40";"CN(CCO)c1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCC(C)(C)C4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"116.0";"nM";"6.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL2063893";"";"None";"907.56";"3";"8.93";"17";"CNC(=O)c1c(-c2cccc(N3CCN(c4ccc(NS(=O)(=O)c5ccc(N[C@H](CCN(C)C)CSc6ccccc6)c([N+](=O)[O-])c5)cc4)CC3)c2)c(-c2ccc(Cl)cc2)cn1C";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"9.04";"0.18";"-0.73";"5.65";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2398295";"";"None";"411.87";"1";"5.74";"12d";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cc(C(=O)O)ccc2Cl)o1";"IC50";"'='";"76000.0";"nM";"4.12";"";"";"UO_0000065";"10.00";"0.20";"-1.62";"4.70";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398249";"";"None";"443.53";"1";"5.10";"63a";"CCN1CC/C(=N/Nc2nc3ccccc3s2)c2cc(-c3cccc(C(=O)O)n3)ccc21";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"15.91";"0.30";"1.96";"7.78";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398256";"";"None";"444.52";"1";"5.43";"63h";"CC1(C)C/C(=N/Nc2nc3ccccc3s2)c2cc(-c3cccc(C(=O)O)n3)ccc2O1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"15.75";"0.30";"1.57";"7.24";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398257";"";"None";"428.52";"1";"5.77";"63i";"CC1CC/C(=N/Nc2nc3ccccc3s2)c2cc(-c3cccc(C(=O)O)n3)ccc21";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"17.10";"0.32";"1.56";"8.38";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398263";"";"None";"414.49";"1";"5.21";"74b";"O=C(O)c1cc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCC3)ccn1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"17.82";"0.34";"2.18";"8.45";"0";"CHEMBL2399237";"Binding affinity to human GST-tagged Bcl-Xl by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398264";"";"None";"400.46";"0";"4.82";"55";"O=C(O)c1cccc(-c2cccc3c2CC/C3=N\Nc2nc3ccccc3s2)n1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.23";"0.27";"0.88";"6.52";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398253";"";"None";"416.46";"0";"4.66";"63e";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCO3)n1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"17.43";"0.33";"2.60";"7.51";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3898420";"";"None";"1000.63";"None";"None";"BDBM156376";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCN(CCO)CC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"298856";"UO_0000065";"8.99";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1576140";"";"None";"368.42";"0";"2.91";"SID26671532";"C=CCn1c(SCC(=O)c2ccc(O)c(O)c2)nnc1-c1cccnc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1538505";"";"None";"365.41";"0";"3.03";"SID4262254";"O=C(Cn1cnc2sc(-c3ccccc3)cc2c1=O)NCc1ccco1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2063881";"";"None";"424.55";"0";"2.77";"5, BM-955";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(N)(=O)=O)cc1[N+](=O)[O-]";"IC50";"'='";"238000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2063886";"";"None";"1047.74";"None";"None";"10, BM-748";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(C#Cc3cccc(-c4c(-c5ccc(Cl)cc5)cn(CC[C@H](O)CO)c4C(=O)NCCCN4CCN(C)CC4)c3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"12.6";"nM";"7.90";"";"";"UO_0000065";"7.54";"None";"None";"None";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4216380";"";"None";"952.61";"3";"8.53";"20";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCc3nc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)sc3C2)C1";"IC50";"'='";"13.2";"nM";"7.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4211496";"";"None";"951.62";"3";"9.13";"16";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCc3sc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3C2)C1";"IC50";"'='";"26.6";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4215940";"";"None";"959.62";"2";"9.11";"10";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCc3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3CC2)C1";"IC50";"'='";"25.6";"nM";"7.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4218253";"";"None";"582.17";"1";"4.98";"37";"Cn1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCC(C)(C)C4)CC3)cc2)n1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3393621";"";"None";"510.16";"2";"6.29";"Maritoclax";"O=C(c1ccccc1O)c1[nH]c(Cl)c(Cl)c1-n1c(C(=O)c2ccccc2O)cc(Cl)c1Cl";"IC50";"'>'";"80000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5035034";"Inhibition of biotinylated Bim BH3 peptide binding to GST-tagged human Bcl-xl expressed in Escherichia coli BL21 (DE3) incubated for 1 hr by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.0 hr";"";""
"CHEMBL2030848";"";"None";"770.91";"2";"7.54";"3e";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1ccc(OC)cc1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"9.49";"0.18";"-0.22";"5.35";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030850";"";"None";"832.98";"2";"9.32";"3g";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1ccc(Oc2ccccc2)cc1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"8.72";"0.16";"-2.06";"5.30";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030855";"";"None";"774.94";"2";"8.51";"3l";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(-c2ccccc2)cc1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"10.18";"0.19";"-0.62";"6.49";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2063880";"";"None";"525.09";"1";"3.59";"4, BM-501";"CN1CCN(CCCNC(=O)c2c(-c3ccccc3)c(-c3ccc(Cl)cc3)cn2CC[C@H](O)CO)CC1";"IC50";"'='";"453000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2066620";"Binding affinity to N-terminus 8X His-tagged human Bcl-xL expressed in Escherichia coli BL21 (DE3) cells after 2 hrs by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BL21-DE3";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062483";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2030864";"";"None";"859.83";"2";"9.94";"3u";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2cccc(Cl)c2)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"9.10";"0.18";"-2.12";"5.98";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031001";"";"None";"801.75";"2";"7.63";"4c";"CCCCN(CCCC)c1nccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(I)cc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"970.0";"nM";"6.01";"";"";"UO_0000065";"7.50";"0.16";"-1.62";"5.34";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031002";"";"None";"825.86";"2";"8.74";"4d";"CCCCN(CCCC)c1nccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4Cc3ccc(Cl)c(Cl)c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"7.45";"0.15";"-2.59";"5.31";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031006";"";"None";"689.88";"2";"7.33";"4h";"CCCCN(CCCC)c1ncc(C)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"10.03";"0.19";"-0.41";"6.15";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031010";"";"None";"750.48";"2";"9.52";"3";"O=C(c1ccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1)N(Cc1ccc(F)cc1)Cc1cc(Cl)cc(Cl)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031017";"";"None";"866.22";"2";"7.95";"17";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(I)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"8.58";"0.19";"-0.52";"6.11";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031023";"";"None";"754.35";"2";"7.91";"26";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2C)c(C)c1Cl";"IC50";"'='";"590.0";"nM";"6.23";"";"";"UO_0000065";"8.26";"0.16";"-1.68";"5.12";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031025";"";"None";"842.46";"2";"7.77";"28";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2COCCCOC)c(C)c1Cl";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"8.95";"0.17";"-0.23";"5.38";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030857";"";"None";"756.92";"2";"6.77";"3n";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(CCCO)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"10.77";"0.20";"1.38";"5.75";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1387693";"";"None";"417.45";"0";"3.75";"SID24814601";"COc1ccc(-n2cccc2/C=C2\C(=N)N3N=C(c4ccco4)SC3=NC2=O)cc1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1310309";"";"None";"385.45";"0";"3.36";"SID863926";"CCn1c(SCC(=O)c2ccc(O)c(O)c2)nnc1-c1ccccc1OC";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL135650";"";"None";"276.24";"0";"1.49";"5D1";"CCOC(=O)c1cc(O)c(=O)c2cc(O)c(O)cc2c1";"IC50";"'='";"73000.0";"nM";"4.14";"";"";"UO_0000065";"14.97";"0.28";"2.65";"3.98";"0";"CHEMBL647263";"Inhibitory concentration against Bcl-xl";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144902";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL2398255";"";"None";"415.48";"0";"4.69";"63g";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCN3)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"19.79";"0.37";"3.53";"8.26";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398277";"";"None";"429.86";"1";"5.88";"22f";"C/C(=N\Nc1nc2c(F)cccc2s1)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"12.29";"0.25";"-0.60";"6.02";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1095757";"";"None";"548.60";"2";"5.42";"12d";"O=C(O)c1cccc(-c2ccc(/C=c3\sc4n(c3=O)C(c3ccc(F)cc3)C3=C(N=4)c4ccccc4CC3)o2)c1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"9.63";"0.18";"-0.14";"6.23";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1098323";"";"None";"560.63";"2";"5.29";"12";"COc1ccccc1C1C2=C(N=c3s/c(=C\c4ccc(-c5cccc(C(=O)O)c5)o4)c(=O)n31)c1ccccc1CC2";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"9.41";"0.18";"-0.01";"5.61";"0";"CHEMBL1120823";"Inhibition of human Bcl-XL";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157133";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3932880";"";"None";"987.59";"3";"8.03";"BDBM156399";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCO[C@H](CO)C2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"298877";"UO_0000065";"8.63";"0.18";"0.49";"5.15";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2325757";"";"None";"958.59";"3";"7.44";"24";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(N3CCN(c4cccc(-c5c(C(=O)NS(C)(=O)=O)cnn5-c5ccc(Cl)cc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"8.66";"0.17";"0.86";"4.32";"0";"CHEMBL2329999";"Binding affinity to BCL-XL (unknown origin) after 2 hrs by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321752";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2031012";"";"None";"740.33";"2";"7.35";"BDBM50384344";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405269";"UO_0000065";"10.40";"0.20";"0.35";"6.33";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2031027";"";"None";"769.37";"2";"6.67";"BDBM50384358";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)c(C)c1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"405303";"UO_0000065";"10.40";"0.20";"1.33";"5.42";"1";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2028179";"";"None";"384.23";"0";"1.75";"SID22401913";"O=[N+]([O-])c1cc(S(=O)(=O)c2ccc([O-])c([N+](=O)[O-])c2)ccc1[O-].[Na+].[Na+]";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1595621";"";"None";"308.39";"0";"2.95";"SID49680194";"C=CCn1c(S)nnc1CSc1ccccc1[N+](=O)[O-]";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1401406";"";"None";"388.40";"0";"2.34";"SID46500226";"COC(=O)CCC(=O)OC1(C)C(=O)C=C2C=C(c3ccsc3)OC=C2C1=O";"IC50";"'='";"27252.0";"nM";"4.57";"";"Not Active";"UO_0000065";"11.75";"0.23";"2.22";"4.76";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1384172";"";"None";"344.33";"1";"5.52";"SID3716320";"c1coc(-c2nc(-c3ccco3)c(-c3ccco3)nc2-c2ccco2)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1482959";"";"None";"304.30";"0";"4.02";"SID57260975";"O=c1cc(-c2ccc(O)c(O)c2)oc2c1ccc1ccccc12";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3924348";"";"None";"1032.65";"None";"None";"BDBM156383";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCN(C[C@@H](O)CF)CC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"298861";"UO_0000065";"8.42";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4228713";"A-1211212";"None";"896.51";"3";"9.44";"EUB0000263";"CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"IC50";"";"753.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4883618";"Time-resolved fluorescence energy transfer (TR-FRET) with BCL2L1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Assay publication: PMID: 25313317 | Target protein length: full length | Target protein type: recombinant protein (GST-Bcl-xL)";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507310";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Num of experiments None 3.0 None";"";""
"CHEMBL4858569";"";"None";"901.02";"3";"8.55";"24c";"CN1CCC(CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(C(F)(F)F)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])C1";"IC50";"'='";"35.7";"nM";"7.45";"";"";"UO_0000065";"8.27";"0.16";"-1.10";"4.49";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL373712";"";"None";"731.94";"2";"6.47";"8e";"COC1(Cc2ccccc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN(C)C)CSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"9.32";"0.18";"0.35";"5.09";"0";"CHEMBL909612";"Displacement of Bad-derived peptide from Bcl-xL by FPA in presence of 10% human serum";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141382";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3703610";"";"None";"999.64";"3";"7.91";"BDBM156390";"N[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCN(CCO)CC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"363106";"UO_0000065";"7.83";"0.16";"-0.09";"4.73";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703614";"";"None";"966.57";"3";"9.24";"BDBM156394";"N#C[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"363110";"UO_0000065";"9.31";"0.19";"-0.24";"6.04";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703614";"";"None";"966.57";"3";"9.24";"BDBM156394";"N#C[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"363111";"UO_0000065";"9.00";"0.18";"-0.54";"5.84";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4847514";"";"None";"971.12";"3";"9.49";"24d";"CC(C)C(=O)N1CCC(CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(C(F)(F)F)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"IC50";"'='";"453.0";"nM";"6.34";"";"";"UO_0000065";"6.53";"0.13";"-3.15";"3.46";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL3915540";"";"None";"1027.65";"None";"None";"BDBM156411";"CNCC(=O)N[C@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"298886";"UO_0000065";"7.51";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3311481";"";"None";"949.56";"3";"7.49";"6";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1csc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)n1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"7.38";"0.15";"-0.48";"4.96";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311482";"";"None";"954.56";"3";"8.04";"7";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CC3(CN(Cc4ccccc4-c4ccc(Cl)cc4)C3)C2)cc1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"7.45";"0.15";"-0.93";"5.54";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311487";"";"None";"959.60";"3";"9.48";"12";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC(Sc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"7.82";"0.16";"-1.97";"6.00";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311492";"";"None";"1013.62";"None";"None";"18";"CCOC(=O)C1(Cc2ccccc2-c2ccc(Cl)cc2)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"7.42";"None";"None";"None";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311493";"";"None";"971.59";"3";"8.54";"19";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC(CO)(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3309307";"";"None";"943.54";"3";"7.43";"21";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3ccncc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"8.29";"0.17";"0.39";"5.54";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3126119";"";"None";"887.05";"3";"8.72";"LC6";"Cc1cc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)ccc1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)nn12";"IC50";"'='";"4.4";"nM";"8.36";"";"";"UO_0000065";"9.42";"0.18";"-0.36";"4.51";"1";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL2030861";"";"None";"672.92";"None";"None";"0Q5";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)CC[Si](C)(C)C)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccccc1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"11.72";"None";"None";"None";"1";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3342332";"A-1155463";"None";"669.80";"2";"6.33";"EUB0000262b";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"13.82";"0.27";"2.93";"8.58";"0";"CHEMBL5210487";"Affinity Biochemical interaction (TR-FRET assay) EUB0000262b BCL2L1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Mode of action: Inhibitor | Negative control: A-1107969 | Protein family: Apoptosis regulator | Recommended concentration = 1.0 µM";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5210307";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Affinity Biochemical Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1155463";"INHIBITOR";""
"CHEMBL383229";"";"None";"568.72";"2";"5.54";"Entry no. 37-3";"CC1(C)CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(NCCSc4ccccc4)c([N+](=O)[O-])c3)cc2)CC1";"IC50";"'='";"78.8";"nM";"7.10";"";"";"UO_0000065";"12.49";"0.25";"1.56";"5.84";"0";"CHEMBL4668636";"Inhibition of FITC-labeled Bak BH3 peptide binding to His6-tagged GST-fused Bcl-xL (unknown origin) expressed in Escherichia coli BL21 preincubated for 10 mins followed by Bak BH3 peptide addition and measured after 30 mins by fluorescence polarization-based competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665682";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"INHIBITOR";""
"CHEMBL4204583";"";"None";"999.64";"3";"9.18";"29";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CNC2(Cn3cnc4ccc(C(=O)NS(=O)(=O)c5ccc(N[C@H](CCN6CCOCC6)CSc6ccccc6)c(S(=O)(=O)C(F)(F)F)c5)cc43)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4213316";"";"None";"600.23";"1";"4.35";"36";"CN1CCN(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCC(C)(C)C4)CC3)cc2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4072989";"";"None";"347.44";"0";"3.09";"13";"Cc1cs/c(=N\C2CCCCC2)n1/N=C/c1cc(O)c(O)c(O)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4052849";"Inhibition of FITC-BID BH3 peptide binding to recombinant GST-tagged C-terminal truncated Bcl-xL (unknown origin) expressed in Escherichia coli BL21 (DE3) after 5 mins by fluorescence polarization assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL2030861";"";"None";"672.92";"None";"None";"3r";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)CC[Si](C)(C)C)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccccc1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"11.72";"None";"None";"None";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030862";"";"None";"727.28";"2";"7.10";"3s";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)CC)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2cccc(Cl)c2)cc1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.42";"0.18";"-0.25";"5.24";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030865";"";"None";"675.85";"2";"7.02";"4a";"CCCCN(CCCC)c1nccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"9.32";"0.18";"-0.72";"5.60";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031008";"";"None";"745.73";"2";"6.87";"4j";"CCCN(CCC)c1ncc(Cl)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"10.53";"0.21";"0.98";"5.67";"0";"CHEMBL2033943";"Inhibition of biotin-labelled Bcl-xL using [FAM]-IWIAQELRRIGDEFNAYY-NH2 as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029199";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031011";"";"None";"747.14";"2";"7.89";"4";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(NS(=O)(=O)c3cc(Cl)cc(Cl)c3O)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"7.18";"0.15";"-2.52";"4.30";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031012";"";"None";"740.33";"2";"7.35";"12";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"10.29";"0.20";"0.27";"6.26";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031029";"";"None";"839.46";"2";"7.05";"32";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN2CCOCC2)c(C)c1Cl";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"9.29";"0.18";"0.75";"5.81";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031030";"";"None";"823.46";"2";"7.81";"33";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CN2CCCC2)c(C)c1Cl";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"9.38";"0.18";"-0.09";"6.18";"0";"CHEMBL2033954";"Inhibition of Bcl-XL using fluoresceinated 18-mer Bim as substrate after 60 mins by FRET analysis";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029223";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3704822";"";"None";"614.65";"3";"7.36";"BDBM174838";"Cc1cc2c(C(=O)Cc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)Cc3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"190.0";"nM";"6.72";"";"320208";"UO_0000065";"10.94";"0.20";"-0.64";"4.32";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL334615";"";"None";"262.22";"0";"1.10";"1163";"COC(=O)c1cc(O)c(=O)c2cc(O)c(O)cc2c1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"21.30";"0.40";"4.49";"5.37";"0";"CHEMBL647263";"Inhibitory concentration against Bcl-xl";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144902";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL106708";"";"None";"216.21";"0";"3.19";"1";"O=C(O)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'>'";"99200.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3893974";"";"None";"784.34";"2";"6.80";"BDBM232409";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@@H]2C(=O)O)c(C)c1Cl";"IC50";"'='";"200.0";"nM";"6.70";"";"405304";"UO_0000065";"8.54";"0.17";"-0.10";"4.21";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2322022";"";"None";"996.57";"3";"9.46";"22";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)Nc2nc(C(F)(F)F)nc3c2CCN(C2CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC2)C3)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"7.23";"0.15";"-2.25";"5.64";"0";"CHEMBL2328209";"Inhibition of Bcl-xL/BAK (unknown origin) interaction";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321763";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3942343";"";"None";"1135.53";"None";"None";"BDBM156384";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN(CCOP(=O)(O)O)CCOP(=O)(O)O)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"298862";"UO_0000065";"7.93";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1824800";"";"None";"443.52";"1";"5.05";"7a";"O=C(NS(=O)(=O)c1ccc(COc2ccccc2)cc1)c1ccc(-c2ccccc2)cc1";"IC50";"'='";"16770.0";"nM";"4.78";"";"";"UO_0000065";"10.77";"0.20";"-0.27";"6.59";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824818";"";"None";"499.38";"1";"5.97";"21";"O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)nc1)c1cccc(-c2cc(Cl)cc(Cl)c2)c1";"IC50";"'='";"2310.0";"nM";"5.64";"";"";"UO_0000065";"11.29";"0.23";"-0.33";"6.60";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL1824832";"";"None";"542.44";"2";"6.97";"35";"CCOc1ccc(Oc2ccc(S(=O)(=O)NC(=O)c3cccc(-c4ccc(Cl)c(Cl)c4)c3)cc2)cc1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"13.03";"0.27";"0.10";"8.65";"0";"CHEMBL1825444";"Displacement of FITC labeled Bak BH3 peptide from Bcl-xL after 10 mins by Fluorescence Polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821700";"1";"Scientific Literature";"J Med Chem";"2011";"None";"";"";""
"CHEMBL4868427";"";"None";"902.01";"3";"9.03";"17b";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'='";"788.0";"nM";"6.10";"";"";"UO_0000065";"6.77";"0.13";"-2.93";"3.55";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL1439414";"";"None";"464.89";"0";"4.63";"SID17512331";"O=C1NC(=O)N(c2cccc(Cl)c2)C(=O)/C1=C\c1ccc(Sc2nc3ccccc3[nH]2)o1";"IC50";"'>'";"12089.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1538897";"";"None";"432.72";"0";"3.91";"SID49669479";"COc1ccc(Cl)cc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1";"IC50";"'='";"32193.0";"nM";"4.49";"";"Not Active";"UO_0000065";"10.38";"0.26";"0.58";"6.20";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1440415";"";"None";"506.49";"1";"4.36";"SID49821901";"Cc1ccc(C(=O)O)cc1-c1ccc(/C=C2\SC(=O)N(CC(=O)Nc3ccc4c(c3)OCO4)C2=O)o1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1985327";"";"None";"534.40";"1";"2.95";"SID26670025";"O=[N+]([O-])c1cc(Cl)cc(/C=N/NC(=S)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2Cl)c1O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1571442";"";"None";"361.42";"0";"3.05";"SID24786051";"COc1ccc(OC)c(NC(=O)COC(=O)c2cc3c(s2)CCC3)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1416189";"";"None";"428.56";"0";"1.90";"SID49822141";"CCN(C(=O)C(C)N1C(=O)/C(=C/c2ccco2)SC1=S)C1CCS(=O)(=O)C1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1467730";"";"None";"322.75";"0";"3.09";"SID4243472";"COc1cc(NC(=O)c2noc3c2CCC3)c(OC)cc1Cl";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3952199";"";"None";"883.51";"2";"7.45";"BDBM232390";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(OCCCN5CCOCC5)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405281";"UO_0000065";"8.37";"0.16";"-0.05";"5.16";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937806";"";"None";"818.35";"2";"7.54";"BDBM232420";"CCCCN(C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl)c1ccc(C(=O)OC)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"405318";"UO_0000065";"8.67";"0.17";"-0.44";"4.80";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890955";"";"None";"984.20";"2";"11.49";"BDBM232438";"CCCCN(C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)ccc(Br)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl)c1cccc(-c2ccc(Cl)cc2)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"405336";"UO_0000065";"7.27";"0.16";"-4.34";"5.88";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2030852";"";"None";"825.39";"2";"9.29";"BDBM50384317";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2ccc(Cl)cc2)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"405343";"UO_0000065";"8.96";"0.17";"-1.89";"5.65";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893805";"";"None";"835.04";"2";"5.76";"BDBM232449";"CCCCN(CCCC)C(=O)c1cn(CCN2CCOCC2)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1";"IC50";"'='";"60.0";"nM";"7.22";"";"405354";"UO_0000065";"8.65";"0.16";"1.46";"4.68";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4855086";"";"None";"888.97";"3";"8.60";"24i";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5CCOC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'='";"1697.0";"nM";"5.77";"";"";"UO_0000065";"6.49";"0.13";"-2.83";"3.41";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"6; ABT-199";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"IC50";"'='";"157.0";"nM";"6.80";"";"";"UO_0000065";"7.83";"0.15";"-1.86";"3.96";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4878411";"";"None";"888.97";"3";"8.74";"24h";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"2, ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"8.70";"0.18";"-0.35";"6.61";"0";"CHEMBL3132072";"Displacement of FITC-Bid from GST-tagged human Bcl-xL expressed in Escherichia coli after 2 hrs by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124878";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1978364";"";"None";"404.25";"0";"2.73";"SID51088556";"COc1ccc(Br)cc1/C=c1\sc2nc(-c3ccco3)nn2c1=O";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3891889";"";"None";"853.53";"2";"8.57";"BDBM232393";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(CNS(=O)(=O)c3ccc4ccc(OCCC5CCCN5C)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405284";"UO_0000065";"9.02";"0.18";"-0.87";"6.58";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927011";"";"None";"1031.51";"None";"None";"BDBM232431";"CCCCN(CCC(=O)NCCN1CCN(C)CC1)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4Cc3ccc(Cl)c(Cl)c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"130.0";"nM";"6.89";"";"405329";"UO_0000065";"6.68";"None";"None";"None";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2030859";"";"None";"728.87";"2";"6.21";"BDBM50384324";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(CO)nn1-c1ccccc1";"IC50";"'='";"8.01";"nM";"8.10";"";"405349";"UO_0000065";"11.11";"0.21";"1.89";"5.71";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1465739";"";"None";"324.43";"0";"2.53";"SID856662";"CCn1c(SC(C)C(=O)O)nc2sc3c(c2c1=O)CCC3";"IC50";"'='";"90143.0";"nM";"4.04";"";"Not Active";"UO_0000065";"12.47";"0.26";"1.52";"5.60";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1488981";"";"None";"424.45";"0";"3.14";"SID26725441";"COC(=O)CCCC1=CC2=CC(=O)C(C)(OC(=O)CCc3ccccc3)C(=O)C2=CO1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1397916";"";"None";"323.33";"0";"2.69";"SID56317574";"O=C(NNC(=O)c1ccccc1F)c1cccc(-n2cccc2)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1350435";"";"None";"304.40";"0";"3.25";"SID26670280";"O=c1c2c3c(sc2[nH]c(=S)n1Cc1ccco1)CCC3";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1312212";"";"None";"476.55";"1";"5.02";"SID22412359";"COc1cccc(NS(=O)(=O)c2ccc3c(c2)C2C=CCC2C(c2ccc(C(=O)O)cc2)N3)c1";"IC50";"'='";"64877.0";"nM";"4.19";"";"Not Active";"UO_0000065";"8.79";"0.17";"-0.83";"4.00";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1510117";"";"None";"264.23";"0";"2.69";"SID4241881";"O=C(Nc1ccc(F)cc1F)c1noc2c1CCC2";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1312353";"";"None";"242.23";"0";"2.71";"SID47200481";"O=Cc1cccc(OC(=O)/C=C/c2ccco2)c1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1348273";"";"None";"350.43";"0";"2.70";"SID49816719";"CC(C)n1c(SCC(=O)Nc2nncs2)nnc1-c1ccco1";"IC50";"'>'";"108803.0";"nM";"";"Outside typical range";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614490";"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3936310";"";"None";"966.57";"3";"9.24";"BDBM156396";"N#C[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"298874";"UO_0000065";"8.38";"0.17";"-1.14";"5.44";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4584015";"";"None";"746.84";"3";"5.47";"9";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)c(S(=O)(=O)F)c2)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"9.32";"0.19";"1.49";"4.22";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4474764";"";"None";"815.89";"2";"6.09";"13";"C#CCN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(-c3ccc(F)cc3)c(S(=O)(=O)F)c2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"8.95";"0.19";"1.21";"4.97";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL1269107";"";"None";"586.60";"2";"5.78";"8; (-)-BI-97D6";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccccc3)c2C1=O";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"12.14";"0.22";"1.34";"4.77";"0";"CHEMBL4052841";"Inhibition of FITC-labeled Bak-BH3 binding to GST-tagged Bcl-xL (unknown origin) preincubated for 5 mins followed by FITC-Bak-BH3 addition measured after 10 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4077940";"";"None";"550.61";"2";"5.23";"43; JY-1-106";"CC(C)Oc1cc(C(=O)Nc2ccc(C(=O)Nc3ccc(C(=O)O)cc3OC(C)C)nc2OC(C)C)ccc1N";"IC50";"'='";"394.0";"nM";"6.41";"";"";"UO_0000065";"11.63";"0.22";"1.17";"3.95";"0";"CHEMBL4052866";"Inhibition of FITC-labeled Bak-BH3 peptide binding to Bcl-xL (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052581";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL2031026";"";"None";"841.48";"2";"7.29";"BDBM50384357";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2COCCN(C)C)c(C)c1Cl";"IC50";"'='";"9.01";"nM";"8.04";"";"405311";"UO_0000065";"9.56";"0.19";"0.76";"6.00";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3125475";"";"None";"502.58";"1";"4.77";"X0D";"CCCN(C(=O)N[C@@H](CSCC(C)C)C(=O)O)C(=O)c1cccc(C#Cc2ccc(F)cc2F)c1";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"9.27";"0.18";"-0.11";"5.37";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4437855";"";"None";"298.27";"0";"2.85";"4";"O=C(O)c1ccc(-c2ccc(F)c(S(=O)(=O)F)c2)cc1";"IC50";"'>'";"99200.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3704827";"";"None";"686.72";"3";"9.28";"BDBM174843";"Cc1cc2c(C(=O)c3cccc4ccccc34)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)c3cccc4ccccc34)c(O)c(O)cc2c1O";"IC50";"'='";"160.0";"nM";"6.80";"";"320213";"UO_0000065";"9.90";"0.18";"-2.48";"4.37";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4851332";"";"None";"930.06";"3";"9.30";"24n";"CCN1CCC(COc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(C(F)(F)F)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"IC50";"'='";"34.6";"nM";"7.46";"";"";"UO_0000065";"8.02";"0.15";"-1.84";"4.57";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL3911725";"";"None";"945.55";"3";"8.26";"BDBM156378";"CN(CCO)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"298858";"UO_0000065";"9.52";"0.20";"0.74";"5.76";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2031014";"";"None";"869.48";"2";"7.06";"BDBM50384363";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(OCCN5CCOCC5)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405278";"UO_0000065";"8.51";"0.17";"0.34";"5.16";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4749218";"";"None";"249.38";"0";"3.38";"Entry no. 37-2";"CC1(C)CCN(c2ccc(C(=O)S)cc2)CC1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4668636";"Inhibition of FITC-labeled Bak BH3 peptide binding to His6-tagged GST-fused Bcl-xL (unknown origin) expressed in Escherichia coli BL21 preincubated for 10 mins followed by Bak BH3 peptide addition and measured after 30 mins by fluorescence polarization-based competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665682";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 0.6667 hr";"";""
"CHEMBL4873467";"";"None";"864.04";"3";"8.02";"17c";"COc1ccc(C2=C(CN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)CCC(C)(C)C2)cc1";"IC50";"'='";"813.0";"nM";"6.09";"";"";"UO_0000065";"7.05";"0.13";"-1.93";"3.36";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4878326";"";"None";"902.99";"3";"8.99";"24g";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'='";"862.0";"nM";"6.06";"";"";"UO_0000065";"6.72";"0.13";"-2.93";"3.58";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4855736";"";"None";"902.99";"3";"8.99";"24j";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5CCCOC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'='";"761.0";"nM";"6.12";"";"";"UO_0000065";"6.78";"0.13";"-2.87";"3.62";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4858527";"";"None";"919.06";"3";"9.71";"24k";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5CCSCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'='";"499.9";"nM";"6.30";"";"";"UO_0000065";"6.86";"0.13";"-3.41";"3.94";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4294191";"";"None";"930.09";"3";"6.64";"28c";"C[C@H]1[C@@H](OCCN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24O3";"IC50";"'='";"624.0";"nM";"6.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4285268";"";"None";"959.14";"3";"6.48";"27f";"C[C@H]1[C@H](N(C)CCN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4278369";"";"None";"930.09";"3";"6.98";"27b";"C[C@H]1[C@@H](CCN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL3944567";"";"None";"987.59";"3";"8.03";"BDBM156402";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCOC[C@H]2CO)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"298880";"UO_0000065";"8.81";"0.18";"0.67";"5.25";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3966210";"";"None";"980.76";"2";"11.39";"BDBM232443";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)ccc(Br)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1ccc(Oc2cccc(Cl)c2)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"405346";"UO_0000065";"7.44";"0.16";"-4.09";"5.33";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965698";"";"None";"702.88";"2";"7.26";"BDBM232451";"CCCCN(CCCC)C(=O)c1cccc(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"70.0";"nM";"7.16";"";"405356";"UO_0000065";"10.18";"0.19";"-0.11";"6.13";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4446373";"";"None";"742.87";"3";"5.22";"11";"CS(=O)(=O)c1cc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c([N+](=O)[O-])c2)ccc1-c1ccc(F)cc1";"IC50";"'='";"1060.0";"nM";"5.97";"";"";"UO_0000065";"8.04";"0.16";"0.75";"3.62";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4204650";"";"None";"516.11";"1";"4.82";"35";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(C)(=O)=O)cc3)CC2)C1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4862150";"";"None";"887.98";"3";"8.64";"24e";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)cc2)C1";"IC50";"'='";"896.6";"nM";"6.05";"";"";"UO_0000065";"6.81";"0.13";"-2.59";"3.52";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL3927598";"";"None";"841.47";"2";"7.66";"BDBM232400";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4C(=O)C3CCCCC3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"230.0";"nM";"6.64";"";"405292";"UO_0000065";"7.89";"0.15";"-1.02";"4.68";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948491";"";"None";"867.54";"2";"8.35";"BDBM232402";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4CCSc3ccccc3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"60.0";"nM";"7.22";"";"405295";"UO_0000065";"8.32";"0.16";"-1.13";"5.78";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963540";"";"None";"790.36";"2";"6.54";"BDBM232411";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3S(=O)(=O)C2)c(C)c1Cl";"IC50";"'='";"130.0";"nM";"6.89";"";"405307";"UO_0000065";"8.71";"0.17";"0.35";"4.42";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3889549";"";"None";"881.50";"2";"5.30";"BDBM232421";"CCCCN(CCC(=O)NCCN1CCN(C)CC1)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405319";"UO_0000065";"8.73";"0.17";"2.40";"4.90";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966290";"";"None";"828.46";"2";"8.51";"BDBM156377";"CN(C)CC[C@@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"1.0";"nM";"9.00";"";"298857";"UO_0000065";"10.86";"0.22";"0.49";"6.20";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3703616";"";"None";"1042.71";"None";"None";"BDBM156397";"CCN(CC)C[C@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"298875";"UO_0000065";"8.63";"None";"None";"None";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4867128";"";"None";"936.45";"3";"9.68";"17f";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(C(F)(F)F)c(Cl)c2)C1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"";""
"CHEMBL4860213";"";"None";"889.01";"3";"8.55";"24a";"CN(C)CCCNc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(C(F)(F)F)cc5)CC(C)(C)CC4)CC3)cc2Oc2cnc3[nH]ccc3c2)cc1[N+](=O)[O-]";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"8.48";"0.16";"-1.01";"4.54";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL376408";"ABT 737";"1.0";"813.45";"2";"7.88";"ABT-737; N3C";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"9.66";"0.19";"-0.03";"6.13";"1";"CHEMBL4378479";"Inhibition of Bcl-xL (unknown origin) by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376822";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3342191";"A-1107969";"None";"674.77";"3";"6.02";"A-1107969";"O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCOc3ccc(-n4ncc5cncnc54)cc3)s1)CC2";"IC50";"";"270.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4883618";"Time-resolved fluorescence energy transfer (TR-FRET) with BCL2L1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Assay publication: PMID: 25313317 | Target protein length: full length | Target protein type: recombinant protein (GST-Bcl-xL)";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507311";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Num of experiments None 3.0 None";"";""
"CHEMBL3928986";"";"None";"774.77";"2";"8.00";"BDBM232382";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)cccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"30.0";"nM";"7.52";"";"405270";"UO_0000065";"9.71";"0.19";"-0.48";"6.18";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890787";"";"None";"866.48";"2";"6.73";"BDBM232398";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(C(=O)N5CCN(C)CC5)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405289";"UO_0000065";"8.54";"0.17";"0.67";"5.09";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942482";"";"None";"857.26";"2";"9.10";"BDBM232415";"CCCCN(CCc1ccc(Cl)c(Cl)c1)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"220.0";"nM";"6.66";"";"405313";"UO_0000065";"7.77";"0.16";"-2.44";"5.47";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899265";"";"None";"939.75";"2";"11.38";"BDBM232440";"CCCCN(C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(Cl)ccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl)c1cccc(-c2cccc(Cl)c2)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"405338";"UO_0000065";"7.87";"0.16";"-3.98";"6.08";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2030864";"";"None";"859.83";"2";"9.94";"BDBM50384329";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(Oc2cccc(Cl)c2)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"405347";"UO_0000065";"9.30";"0.18";"-1.94";"6.11";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921891";"";"None";"777.00";"2";"7.01";"BDBM232447";"CCCCN(CCCC)C(=O)c1cn(CCCN(C)C)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"405352";"UO_0000065";"9.68";"0.18";"0.51";"6.02";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957861";"";"None";"740.33";"2";"7.03";"BDBM232453";"CCCCN(CCCC)c1ncc(Cl)c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1";"IC50";"'='";"80.0";"nM";"7.10";"";"405358";"UO_0000065";"9.59";"0.19";"0.07";"5.34";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893949";"";"None";"870.49";"3";"8.28";"BDBM156393";"O=C(NS(=O)(=O)c1ccc(N[C@@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"298871";"UO_0000065";"10.34";"0.20";"0.72";"5.83";"0";"CHEMBL3705975";"Fluorescence Polarization: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502).Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP') assays may be developed using a c-terminal 6.times.HIS tagged Bcl-2 (aa 1-204) and a C-terminal 6.times.HIS tagged Bcl-X.sub.L (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluores.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638929";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3892056";"";"None";"774.77";"2";"8.00";"BDBM232385";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(Cl)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"90.0";"nM";"7.05";"";"405274";"UO_0000065";"9.09";"0.18";"-0.95";"5.79";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4284025";"";"None";"960.12";"3";"7.00";"34c";"C[C@@H]1CC[C@H]2[C@@H](C)C(OCCNC3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4290795";"";"None";"946.09";"3";"5.61";"29a";"C[C@H]1[C@@H](OCCN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@]3(C)O[C@]24[C@H]1CC[C@@H](C)[C@@H]4C[C@H]3O";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4282932";"";"None";"928.08";"3";"6.58";"28d";"C[C@H]1[C@@H](CC(=O)N2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24O3";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1269074";"";"None";"626.75";"2";"7.63";"BDBM142752";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCC3CCCCC3)C2=O)C(=O)c2cc(O)c(O)c(CCC3CCCCC3)c2C1=O";"IC50";"'='";"12650.0";"nM";"4.90";"";"278894";"UO_0000065";"7.81";"0.15";"-2.73";"3.28";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4529727";"";"None";"746.84";"3";"5.47";"7";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)c(S(=O)(=O)F)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"9.91";"0.20";"1.93";"4.48";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL443684";"NAVITOCLAX";"3.0";"974.63";"3";"8.83";"ABT-263";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'<'";"8.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL1269072";"";"None";"642.62";"2";"5.45";"BDBM142749";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3C(=O)Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(C(=O)Cc3ccccc3)c2C1=O";"IC50";"'='";"340.0";"nM";"6.47";"";"278898";"UO_0000065";"10.07";"0.18";"1.02";"3.53";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3703613";"";"None";"870.49";"3";"8.28";"BDBM156393";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"363109";"UO_0000065";"10.34";"0.20";"0.72";"5.83";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703599";"";"None";"828.46";"2";"8.51";"BDBM156377";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"1.0";"nM";"9.00";"";"363095";"UO_0000065";"10.86";"0.22";"0.49";"6.20";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703601";"";"None";"959.57";"3";"8.65";"BDBM156380";"CCN(CCO)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"0.8";"nM";"9.10";"";"363097";"UO_0000065";"9.48";"0.19";"0.45";"5.82";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703600";"";"None";"945.55";"3";"8.26";"BDBM156378";"CN(CCO)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"363096";"UO_0000065";"9.52";"0.20";"0.74";"5.76";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703606";"";"None";"1025.53";"None";"None";"BDBM156386";"CN(CCOP(=O)(O)O)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"1.0";"nM";"9.00";"";"363102";"UO_0000065";"8.78";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4111781";"";"None";"1014.65";"None";"None";"BDBM204937";"CCNC[C@@H]1COCCN1CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"0.5";"nM";"9.30";"";"363114";"UO_0000065";"9.17";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703627";"";"None";"1027.65";"None";"None";"BDBM156411";"CNCC(=O)N[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"19.0";"nM";"7.72";"";"363124";"UO_0000065";"7.51";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3358688";"";"None";"402.94";"1";"6.21";"I1";"O=C(CC(Sc1ccc(Cl)cc1)C(=O)O)c1ccc(C2CCCCC2)cc1";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"11.78";"0.24";"-1.47";"8.73";"0";"CHEMBL3383562";"Displacement of F-bid from human recombinant N-terminal His-tagged Bcl-xL (1 to 209) expressed in Escherichia coli BL21(DE3) after 30 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3311330";"";"None";"941.56";"3";"8.22";"2";"N=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"7.65";"0.16";"-1.02";"5.33";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1236741";"";"None";"779.00";"2";"7.23";"X0J";"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cc2)cc1[N+](=O)[O-]";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"10.22";"0.20";"0.73";"6.21";"0";"CHEMBL3406793";"Inhibition of GST-tagged Bcl-xL (unknown origin) measured after 1 hr incubation by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3399933";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4592905";"";"None";"664.78";"2";"5.81";"10";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"11.32";"0.22";"1.71";"5.75";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4286311";"";"None";"914.09";"3";"7.05";"28b";"C[C@H]1[C@@H](CCN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24O3";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4292460";"";"None";"968.02";"3";"7.40";"27a";"C[C@@H]1CC[C@H]2C(CN3CCN(c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c([N+](=O)[O-])c5)c(Oc5cnc6[nH]ccc6c5)c4)CC3)=C(C(F)(F)F)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"'='";"71.9";"nM";"7.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4524407";"";"None";"298.27";"0";"2.85";"2";"O=C(O)c1ccc(-c2ccc(F)cc2)c(S(=O)(=O)F)c1";"IC50";"'>'";"99200.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4464321";"";"None";"298.27";"0";"2.85";"3";"O=C(O)c1ccc(-c2ccc(F)cc2S(=O)(=O)F)cc1";"IC50";"'>'";"99200.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL3703607";"";"None";"1080.61";"None";"None";"BDBM156387";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCN(CCOP(=O)(O)O)CC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"363103";"UO_0000065";"8.33";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3342332";"A-1155463";"None";"669.80";"2";"6.33";"EUB0000262";"CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1";"IC50";"";"0.55";"nM";"";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL4883618";"Time-resolved fluorescence energy transfer (TR-FRET) with BCL2L1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Assay publication: PMID: 25313317 | Target protein length: full length | Target protein type: recombinant protein (GST-Bcl-xL)";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507311";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Num of experiments None 3.0 None";"";""
"CHEMBL2398259";"";"None";"464.53";"0";"4.05";"67b";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCS3(=O)=O)n1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"15.30";"0.30";"3.06";"5.84";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3703611";"";"None";"957.56";"3";"8.66";"BDBM156391";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"78.0";"nM";"7.11";"";"363107";"UO_0000065";"7.42";"0.15";"-1.55";"4.89";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3137309";"VENETOCLAX";"4.0";"868.46";"3";"8.66";"ABT-199; 1";"CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1";"IC50";"'='";"52.7";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4277317";"";"None";"944.08";"3";"6.51";"27g";"C[C@H]1[C@@H](CC(=O)N2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'='";"109.0";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL4557431";"";"None";"3379.80";"None";"None";"BH3 bim";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](CO)NC(=O)CNC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)C(C)C";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"2.47";"None";"None";"None";"0";"CHEMBL4378479";"Inhibition of Bcl-xL (unknown origin) by surface plasmon resonance assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4376822";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1269076";"";"None";"642.70";"2";"6.79";"BDBM142754";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3CCc3ccc(C)cc3)C2=O)C(=O)c2cc(O)c(O)c(CCc3ccc(C)cc3)c2C1=O";"IC50";"'='";"3100.0";"nM";"5.51";"";"278891";"UO_0000065";"8.57";"0.16";"-1.28";"3.69";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704830";"";"None";"772.44";"3";"8.89";"BDBM174846";"Cc1cc2c(C(=O)Cc3cccc(Br)c3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)Cc3cccc(Br)c3)c(O)c(O)cc2c1O";"IC50";"'='";"1310.0";"nM";"5.88";"";"320216";"UO_0000065";"7.62";"0.17";"-3.01";"3.78";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL551288";"APOGOSSYPOL";"None";"462.54";"2";"6.76";"BDBM31802";"Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O";"IC50";"'='";"3690.0";"nM";"5.43";"";"320207";"UO_0000065";"11.75";"0.22";"-1.33";"4.48";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704823";"";"None";"574.67";"3";"7.48";"BDBM174839";"CCc1cc2c(C(=O)CC(C)C)c(O)c(O)cc2c(O)c1-c1c(CC)cc2c(C(=O)CC(C)C)c(O)c(O)cc2c1O";"IC50";"'='";"1300.0";"nM";"5.89";"";"320209";"UO_0000065";"10.24";"0.19";"-1.59";"3.78";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3704826";"";"None";"586.60";"3";"6.97";"BDBM174842";"Cc1cc2c(C(=O)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"2900.0";"nM";"5.54";"";"320212";"UO_0000065";"9.44";"0.17";"-1.43";"3.56";"0";"CHEMBL3705661";"Fluorescence Polarization Assays: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively.After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model (SigmaPlot 10.0.1, Systat Software, Inc., San Jose, Calif., USA).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639281";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3940231";"";"None";"870.86";"2";"10.07";"BDBM232419";"CCCCN(C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl)c1cccc(-c2cccc(Cl)c2)c1";"IC50";"'='";"160.0";"nM";"6.80";"";"405317";"UO_0000065";"7.80";"0.15";"-3.27";"5.59";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945459";"";"None";"969.13";"2";"9.66";"BDBM232423";"CCCCN(Cc1ccc(Cl)c(Cl)c1)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccc(I)cc4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"80.0";"nM";"7.10";"";"405321";"UO_0000065";"7.32";"0.17";"-2.56";"5.83";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938217";"";"None";"920.36";"2";"8.42";"BDBM232425";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)CCN4Cc3ccc(Cl)c(Cl)c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405323";"UO_0000065";"8.04";"0.16";"-1.02";"5.10";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939961";"";"None";"714.96";"None";"None";"BDBM232442";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)CC[Si](C)(C)C)cc2C(=O)N2CCc3ccccc3C2)c(C(=O)OCC)nn1-c1ccccc1";"IC50";"'='";"30.0";"nM";"7.52";"";"405341";"UO_0000065";"10.52";"None";"None";"None";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2030856";"";"None";"742.90";"2";"6.38";"BDBM50384321";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(CCO)cc1";"IC50";"'='";"6.14";"nM";"8.21";"";"405345";"UO_0000065";"11.05";"0.21";"1.83";"5.79";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3309308";"";"None";"943.54";"3";"7.43";"22";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3cccnc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"8.06";"0.16";"0.17";"5.38";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4473013";"";"None";"746.84";"3";"5.47";"8";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2S(=O)(=O)F)cc1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"8.94";"0.18";"1.21";"4.05";"0";"CHEMBL4409524";"Inhibition of recombinant human N-terminal GST-tagged Bcl-xl (1 to 209 residues) expressed in Escherichia coli using HyLite Fluor 647-labeled BIM peptide as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4406861";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"None";"";"";""
"CHEMBL4209752";"";"None";"864.45";"2";"6.81";"50";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NC5(CN6CCOCC6)CC5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"55.3";"nM";"7.26";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4202464";"";"None";"870.41";"2";"7.43";"51";"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NC5(CN6CC(F)(F)C6)CC5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1";"IC50";"'='";"342.0";"nM";"6.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4182825";"Displacement of Bad-derived peptide from Bcl-XL (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177735";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL2398170";"";"None";"394.48";"0";"4.95";"48";"C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(C(=O)O)n2)s1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"15.01";"0.30";"0.97";"6.77";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2398254";"";"None";"432.53";"1";"5.37";"63f";"O=C(O)c1cccc(-c2ccc3c(c2)/C(=N\Nc2nc4ccccc4s2)CCS3)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"18.16";"0.36";"2.48";"8.98";"0";"CHEMBL2399239";"Binding affinity to human GST-tagged Bcl-Xl by luminescence proximity assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396645";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL408194";"OBATOCLAX";"3.0";"317.39";"0";"4.49";"3";"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C";"IC50";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"16.79";"0.30";"0.84";"10.02";"0";"CHEMBL3822336";"Inhibition of FITC-labeled Bid BH3 peptide binding to human GST-tagged Bcl-XL lacking C-terminal transmembrane domain expressed in Escherichia coli XL-1 Blue cells preincubated for 10 mins followed by FITC-labeled Bid BH3 peptide addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"XL-1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3817778";"1";"Scientific Literature";"Medchemcomm";"2016";"None";"";"";""
"CHEMBL4295247";"";"None";"944.12";"3";"7.37";"27c";"C[C@H]1[C@@H](CCCN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4264660";"Inhibition of FAM-labelled Bax binding to Bcl-xL (unknown origin) after 30 mins by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261603";"1";"Scientific Literature";"Eur J Med Chem";"2018";"None";"";"";""
"CHEMBL1269012";"";"None";"756.81";"3";"5.67";"BDBM142748";"CCc1ccc(CCNC(=O)c2c(O)c(O)cc3c2C(=O)C(C)=C(C2=C(C)C(=O)c4c(cc(O)c(O)c4C(=O)NCCc4ccc(CC)cc4)C2=O)C3=O)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"278900";"UO_0000065";"8.75";"0.16";"0.95";"3.19";"1";"CHEMBL3705614";"Fluorescence Polarization Assay: A Bak BH3 peptide (F-BakBH3) (GQVGRQLAIIGDDINR (SEQ ID NO:1)) was labeled at the N-terminus with fluorescein isothiocyanate (FITC) (Molecular Probes) and purified by HPLC. For competitive binding assays, 100 nM GST-BCL-XL DTM protein was preincubated with the tested compound at varying concentrations in 47.5 uL PBS (pH=7.4) in 96-well black plates at room temperature for 10 min, then 2.5 uL of 100 nM FITC-labeled Bak BH3 peptide was added to produce a final volume of 50 uL. The wild-type and mutant Bak BH3 peptides were included in each assay plate as positive and negative controls, respectively. After 30 min incubation at room temperature, the polarization values in millipolarization units were measured at excitation/emission wavelengths of 480/535 nm with a multilabel plate reader (PerkinElmer). IC50 was determined by fitting the experimental data to a sigmoidal dose-response nonlinear regression model.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638406";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL538616";"";"None";"700.79";"3";"7.58";"26; BI-97C1";"Cc1cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NCC(C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"9.29";"0.17";"-1.07";"3.62";"0";"CHEMBL5241832";"Inhibition of Bcl-xl (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241079";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4297482";"AZD-5991";"1.0";"672.28";"2";"8.18";"AZD5991";"Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"11.07";"0.22";"-0.74";"8.55";"0";"CHEMBL5096359";"Inhibition of N-terminal GST-tagged Bcl-xL (1 to 209 residues) (unknown origin) expressed in Escherichia coli using fFluor 647-labeled BAK peptide GGGQVGRQLAIIGDDINR as substrate incubated for 120 to 180 mins by TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096144";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";"Time_Lower = 120.0 min | Time_Upper = 180.0 min";"INHIBITOR";""
"CHEMBL3311329";"";"None";"942.55";"3";"8.04";"1";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"7.63";"0.16";"-0.85";"5.60";"0";"CHEMBL3369472";"Inhibition of human BCL-xL overexpressed in mouse FDC-P1 cells assessed as cell viability after 24 hrs by Cell Titer Glo assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"FDC-P1";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3309312";"";"None";"1029.67";"None";"None";"27";"CN(C)CCOc1cccc(-c2ccc(Cl)cc2)c1CN1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3369468";"Inhibition of c-terminal 6xHis-tagged Bcl-xL (amino acids 1 to 209) (unknown origin) preincubated for 1 hr prior to substrate addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351631";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL555017";"GAMBOGIC ACID";"None";"628.76";"2";"7.24";"28";"CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(=C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4=O)C3=O";"IC50";"'='";"1470.0";"nM";"5.83";"";"";"UO_0000065";"9.28";"0.17";"-1.41";"4.89";"0";"CHEMBL5241836";"Displacement of fluorescein tagged BID BH3 peptide from GST-tagged recombinant Bcl-xl (unknown origin) by fluorescence polarization-based competitive binding assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241079";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3703598";"";"None";"1000.63";"None";"None";"BDBM156376";"O=C(NS(=O)(=O)c1ccc(N[C@H](CCN2CCN(CCO)CC2)CSc2ccccc2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCC([C@@H](O)c3ccccc3-c3ccc(Cl)cc3)CC2)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"363094";"UO_0000065";"8.99";"None";"None";"None";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703609";"";"None";"958.59";"3";"8.61";"BDBM156389";"CCN(CCO)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](N)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"3.0";"nM";"8.52";"";"363105";"UO_0000065";"8.89";"0.18";"-0.09";"5.26";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703626";"";"None";"956.58";"3";"8.63";"BDBM156410";"N[C@@H](c1ccccc1-c1ccc(Cl)cc1)C1CCN(c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H](CCN4CCOCC4)CSc4ccccc4)c(S(=O)(=O)C(F)(F)F)c3)cc2)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"363123";"UO_0000065";"7.82";"0.16";"-1.15";"4.95";"0";"CHEMBL3887910";"Fluorescence Polarization Assay: Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of known methods. One such assay is a sensitive and quantitative in vitro binding assay using fluorescence polarization ('FP') described by Wang, J.-L.; Zhang, Z-J.; Choksi, S.; Sjam. S.; Lu, Z.; Croce, C. M.; Alnemri, E. S.; Komgold, R.; Huang, Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000, 60, 1498-1502). Additionally, the binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-e) to Bcl-2 protein in vitro was determined by a competitive binding assay based on fluorescence polarization. For example, fluorescence polarization ('FP')assays may be developed using a c-terminal 6XHIS tagged Bcl-2 (aa 1-204) and a C-terminal 6XHIS tagged Bcl-XL (aa 1-209). The tracer may be a synthetic peptide BH-3 peptide Bim conjugated to Fluorescein isothiocyanate (FITC-DLRPEIRIAQELRRIGDEFNETYTRR). Dilutions of either Bcl-2 (1.3 nM) or Bcl-XL (0.8 nM) may be added to serial dilutions of antagonist and incubated for one hour prior to the addition of 2 nM of fluorescent peptide tracer (Anaspec, Fremont, Calif.) in the assay buffer. Final assay buffer conditions may be 20 mM HEPES, pH 7.5, 1 mM DTT, 0.005% Tween-20 and 50 mM NaCl. Samples may be read after 20-minute incubation. Fluorescence polarization values may be plotted as a function of the antagonist concentration.";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886500";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4297482";"AZD-5991";"1.0";"672.28";"2";"8.18";"AZD5991";"Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"6.61";"0.13";"-3.74";"5.10";"0";"CHEMBL5035036";"Inhibition of Fluor 647-labeled Bim peptide C binding to human N-terminal GST-tagged Bcl-xL expressed in Escherichia coli incubated for 120 to 180 mins by lanthascreen TR-FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5034015";"1";"Scientific Literature";"J Med Chem";"2021";"None";"Time_Lower = 120.0 min | Time_Upper = 180.0 min";"INHIBITOR";""
"CHEMBL4551344";"A-1210227";"None";"904.37";"3";"8.88";"EUB0000746a";"O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5213989";"Selectivity interaction (TR-FRET assay) EUB0000746a BCL2L1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Apoptosis regulator";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Selectivity Comments: CellTiter-Glo Luminescent Cell Viability Assay (BCL-XL dependent cell line H146): EC50 >5 µM, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1211212; | Selectivity Remarks: In-vitro potency | Selectivity Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1211212";"";""
"CHEMBL2031017";"";"None";"866.22";"2";"7.95";"BDBM50384348";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(I)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"405272";"UO_0000065";"8.54";"0.19";"-0.55";"6.08";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1094250";"1,1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMETHYL-N5-((R)-2-PHENYLPROPYL)-N5'-((R)-2-PHENYLPROPYL)-2,2'-BINAPHTHYL-5,5'-DICARBOXAMIDE (ATROPISOMERIC MIX)";"None";"700.79";"3";"7.58";"BI-97C1";"Cc1cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(=O)NC[C@H](C)c3ccccc3)c(O)c(O)cc2c1O";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"9.29";"0.17";"-1.07";"3.62";"1";"CHEMBL5234920";"Inhibition of BH3 peptide binding to Bcl-xL (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5233252";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"INHIBITOR";""
"CHEMBL1269107";"";"None";"586.60";"2";"5.78";"27; BI-97D6";"CC1=C(C2=C(C)C(=O)c3c(cc(O)c(O)c3Cc3ccccc3)C2=O)C(=O)c2cc(O)c(O)c(Cc3ccccc3)c2C1=O";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"12.14";"0.22";"1.34";"4.77";"1";"CHEMBL5241832";"Inhibition of Bcl-xl (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5241079";"1";"Scientific Literature";"Eur J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4866646";"";"None";"917.02";"3";"9.38";"24l";"CC(Oc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(C(F)(F)F)cc5)CC(C)(C)CC4)CC3)cc2Oc2cnc3[nH]ccc3c2)cc1[N+](=O)[O-])C1CCOCC1";"IC50";"'='";"617.6";"nM";"6.21";"";"";"UO_0000065";"6.77";"0.13";"-3.17";"3.67";"0";"CHEMBL4828453";"Displacement of Bak derived peptide from Bcl-xL (unknown origin) measured after 15 mins by microplate reader assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825763";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.25 hr";"INHIBITOR";""
"CHEMBL4228713";"A-1211212";"None";"896.51";"3";"9.44";"EUB0000263b";"CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1";"IC50";"'='";"753.0";"nM";"6.12";"";"";"UO_0000065";"6.83";"0.13";"-3.32";"3.56";"0";"CHEMBL5213807";"Selectivity interaction (TR-FRET assay) EUB0000263b BCL2L1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"Protein family: Apoptosis regulator";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5212743";"65";"Literature data from EUbOPEN Chemogenomic Library";"";"2023";"None";"Selectivity Comments: CellTiter-Glo Luminescent Cell Viability Assay (BCL-XL dependent cell line H146): EC50 >5 µM, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1211212; | Selectivity number of off-targets = 0.0 None | Selectivity Remarks: In-vitro potency | Selectivity Source Knowledge: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/A-1211212";"";""
"CHEMBL3901024";"";"None";"774.77";"2";"8.00";"BDBM232383";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4cccc(Cl)c4c3)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"70.0";"nM";"7.16";"";"405271";"UO_0000065";"9.23";"0.18";"-0.85";"5.88";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947141";"";"None";"883.25";"2";"7.77";"BDBM232407";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4c(c3)c(I)cn4CC)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"80.0";"nM";"7.10";"";"405300";"UO_0000065";"8.03";"0.18";"-0.67";"5.61";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962921";"";"None";"915.15";"2";"8.69";"BDBM232408";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3cc(Br)c4c(c3)c(Br)cn4CC)cc2C(=O)N2CCc3ccccc3C2)c(C)c1Cl";"IC50";"'='";"20.0";"nM";"7.70";"";"405301";"UO_0000065";"8.41";"0.19";"-0.99";"6.08";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2031025";"";"None";"842.46";"2";"7.77";"BDBM50384356";"CCCCN(CCCC)C(=O)c1nn(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2Cc3ccccc3C[C@H]2COCCCOC)c(C)c1Cl";"IC50";"'='";"30.0";"nM";"7.52";"";"405308";"UO_0000065";"8.93";"0.17";"-0.25";"5.37";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918064";"";"None";"1002.38";"None";"None";"BDBM232437";"Cc1c(Cl)c(C(=O)NCc2ccc(-c3ccc(CC(=O)O)cc3)cc2)nn1-c1ccc(C(=O)NS(=O)(=O)c2ccc3c(c2)CCN3Cc2ccc(Cl)c(Cl)c2)cc1C(=O)N1CCc2ccccc2C1";"IC50";"'='";"8070.0";"nM";"5.09";"";"405335";"UO_0000065";"5.08";"None";"None";"None";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982792";"";"None";"788.92";"2";"5.58";"BDBM232444";"CCCCc1c(-c2ccc(C(=O)NS(=O)(=O)c3ccc4ccccc4c3)cc2C(=O)N2CCc3ccccc3C2)c(CO)nn1-c1ccc(OCC(O)CO)cc1";"IC50";"'='";"4.96";"nM";"8.30";"";"405348";"UO_0000065";"10.53";"0.20";"2.72";"4.85";"0";"CHEMBL3888504";"Fluorescence Resonance Energy Transfer Assay (FRET): The assays were performed in black flat-bottom 384-well plates. The final assay volume was 55 μl prepared from additions of Biotin-Bcl-xL (Bcl-xL: GENBANK® Accession No. Q07817), fluoresceinated 18-mer BIM peptide (NH2-YYANFEDGIRRLEQAIWI-[FAM]) (SEQ ID NO: 1), Streptavidin-Terbium FRET detection reagent, and test compounds in assay buffer consisting of 20 mM Sodium Phosphate, 1 mM EDTA, 50 mM NaCl, and 0.05% Pluronic Acid. The reaction was incubated at room temperature for 60 minutes. After 60 minutes, 5 μL of Streptavidin-Terbium FRET detection reagent (Perkin Elmer) was added to the reaction mixture and incubated at room temperature in the dark for 30 mins. The FRET signal generated by the reaction was detected on the Envision Plate Reader Inhibition data were calculated from FRET values generated by the no protein control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay was 10 nM Bcl-xL, 5 nM fluo";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886736";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3703600";"";"None";"945.55";"3";"8.26";"3; AZD4320";"CN(CCO)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC([C@@H](O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1S(=O)(=O)C(F)(F)F";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"8.83";"0.18";"0.09";"5.34";"0";"CHEMBL5108716";"Displacement of synthetic peptide tracer conjugated to fluorescein isothiocyanate from C-terminal 6xHis-tagged Bcl-xL (1 to 209 residues) (unknown origin) preincubated for 1 hr followed by tracer addition measured after 20 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4625";"Apoptosis regulator Bcl-X";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107957";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.333 hr";"INHIBITOR";""
